Section 41

EurekaMag PDF full texts Chapter 40,243


Ambrosio, S.; D.O.iveira, J.R.; Bartrons, R. 1992: HPLC analysis of hexosamine phosphates in biological samples. Journal of Biochemical and Biophysical Methods 25(4): 237-244
Sweeting, R.M.; Eales, J.G. 1992: HPLC analysis of in vitro hepatic deiodination products of thyroid hormones in the rainbow trout, Oncorhynchus mykiss. General and Comparative Endocrinology 85(3): 367-375
Blanchard, J.; Weber, C.W.; Shearer, L.E. 1990: HPLC analysis of methylxanthines in human breast milk. Journal of Chromatographic Science 28(12): 640-642
Marini, D.; Balestrieri, F.; Pollino, G. 1986: HPLC analysis of miokamycin and its principle impurities. Bollettino Chimico Farmaceutico 125(6): 193-196
Hoenig, M.; Matschinsky, F.M. 1987: HPLC analysis of nucleotide profiles in glucose-stimulated perifused rat islets. Metabolism, Clinical and Experimental 36(3): 295-301
Wongyai, S.; Oefner, P.; Bonn, G. 1988: HPLC analysis of polyamines and their acetylated derivatives in the picomole range using benzoyl chloride and 3,5-dinitrobenzoyl chloride as derivatizing agent. Biomedical Chromatography: Bmc 2(6): 254-257
Rogers, K.L.; Philibert, R.A.; Allen, A.J.; Molitor, J.; Wilson, E.J.; Dutton, G.R. 1987: HPLC analysis of putative amino acid neurotransmitters released from primary cerebellar cultures. Journal of Neuroscience Methods 22(2): 173-179
Klimes, J.; Sochor, J.; Sedlácek, J.; Zahradnícek, M. 1988: HPLC analysis of salicylic acid in plasma with detection in a visible region. Ceskoslovenska Farmacie 37(4): 172-174
Lherisson, C.; Estival, A.; Pradayrol, L.; Vaysse, N. 1989: HPLC analysis of somatostatin peptides secreted by a rat pancreatic endocrine cell line (RINT3): stimulation studies. Hormone Research 32(1-3): 67-70
Sperk, G.; Reynolds, G.P.; Riederer, P. 1987: HPLC analysis of somatostatin related peptides in putamen of Huntington's disease patients. Journal of Neural Transmission 69(1-2): 153-160
Layne, W.W.; Kassis, A.I.; Van den Abbeele, A.; Kinsey, B.M.; Adelstein, S.J. 1987: HPLC analysis of the dissociation and recombination of rabbit immunoglobulin G. Journal of Immunological Methods 96(2): 195-199
Mazzei, M.; Sottofattori, E.; Balbi, A.; Bottino, G.B. 1992: HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state. Farmaco 47(5 Suppl): 769-777
Strasberg, P.M.; Warren, I.; Skomorowski, M.A.; Lowden, J.A. 1985: HPLC analysis of urinary sulfatide: an aid in the diagnosis of metachromatic leukodystrophy. Clinical Biochemistry 18(2): 92-97
Casy, A.F.; Cooper, A.D.; Jefferies, T.M.; Gaskell, R.M.; Greatbanks, D.; Pickford, R. 1991: HPLC and 1H-NMR study of chiral recognition in some thromboxane antagonists induced by beta-cyclodextrin. Journal of Pharmaceutical and Biomedical Analysis 9(10-12): 787-792
Holt, D.W.; Johnson, A. 1992: HPLC and CYCLO-Trac SP radioimmunoassay compared for monitoring cyclosporine. Clinical Chemistry 38(3): 442-443
Göke, B.; Keim, V. 1992: HPLC and FPLC. Recent progress in the use of automated chromatography systems for resolution of pancreatic secretory proteins. International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 11(2): 109-116
Cui, J.F.; Zhang, G.D.; Wang, M.Z. 1985: HPLC and TLC-densitometry determination of alkaloidal constituents in Sophora flavescens and Sophora lopecuroides. Yao Xue Xue Bao 20(1): 59-66
Tsuji, K.; Goetz, J.F. 1978: HPLC as a rapid means of monitoring erythromycin and tetracycline fermentation processes. Journal of Antibiotics 31(4): 302-308
Vorberg, E. 1992: HPLC assay for serum glycated albumin. Diabetologia 35(7): 699-700
Fairbanks, L.D.; Duley, J.A.; Shores, A.J.; Simmonds, H.A. 1991: HPLC assay of uridine monophosphate synthase (UMPS) in chorionic villus samples (CVS) and erythrocytes (RBC). Advances in Experimental Medicine and Biology 309b: 35-38
Larsson, M.; Forsman, A.; Hallgren, J. 1988: HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: a methodological study with clinical applications. Methods and Findings in Experimental and Clinical Pharmacology 10(7): 453-460
Larsson, M.; Forsman, A.; Hallgren, J. 1987: HPLC assays of noradrenaline and dopamine in CSF samples from drug-free subjects. Methods and Findings in Experimental and Clinical Pharmacology 9(10): 669-672
Waldrep, J.C.; Schulte, J.R. 1989: HPLC chromatofocusing of human immunoglobulins. Journal of Immunological Methods 118(2): 273-277
Gil-Loyzaga, P.; Parés-Herbute, N. 1989: HPLC detection of dopamine and noradrenaline in the cochlea of adult and developing rats. Brain Research. Developmental Brain Research 48(1): 157-160
Brode, E.; Kripp, U.; Breckwoldt, W. 1988: HPLC determination of 5-hydroxypropafenone in plasma with electrochemical detection. Methods and Findings in Experimental and Clinical Pharmacology 10(5): 319-329
Kitsos, M.; Massolini, G.; Gandini, C.; Caccialanza, G. 1989: HPLC determination of K-hetacillin and Na-dicloxacillin in oily suspension. Bollettino Chimico Farmaceutico 128(7-8): 229-231
Förster, I.; Junghänel, H.; Kropfgans, F. 1988: HPLC determination of L-dopa and carbidopa in Isicom tablets. Die Pharmazie 43(1): 47
Yamamoto, M.; Ishiwata, H.; Yamada, T.; Tanimura, A.; Tomita, I. 1986: HPLC determination of N-nitrosomethylurea in biological fluids by reaction with 4-nitrothiophenol. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 24(3): 247-250
Yu, Z.; Leung, M.K.; Ramamurthy, N.S.; McNamara, T.F.; Golub, L.M. 1992: HPLC determination of a chemically modified nonantimicrobial tetracycline: biological implications. Biochemical Medicine and Metabolic Biology 47(1): 10-20
Maguire, M.H.; Westermeyer, F.A.; King, C.R. 1986: HPLC determination of adenosine, inosine and hypoxanthine levels in human term placenta. Advances in Experimental Medicine and Biology 195 Pt A: 583-585
Ficarra, R.; Ficarra, P.; Tommasini, A.; Calabrò, M.L.; Guarniera Fenech, C. 1985: HPLC determination of atenolol and chlorthalidone associated in pharmaceutical preparations. Il Farmaco; Edizione Pratica 40(9): 307-312
Catanese, B.; Lagana, A.; Marino, A.; Picollo, R.; Rotatori, M. 1986: HPLC determination of benzydamine and its metabolite N-oxide in plasma following oral administration or topical application in man, using fluorimetric detection. Pharmacological Research Communications 18(4): 385-403
Loullis, C.C.; Felten, D.L.; Shea, P.A. 1979: HPLC determination of biogenic amines in discrete brain areas in food deprived rats. Pharmacology Biochemistry and Behavior 11(1): 89-93
Martelli, A.; Belliardo, F. 1987: HPLC determination of caffeine in food and dietetic products. Bollettino Chimico Farmaceutico 126(2): 93-98
Marini, D.; Balestrieri, F.; Pollino, G.; Belli, F. 1987: HPLC determination of cefotetan and its principle impurities. Bollettino Chimico Farmaceutico 126(2): 60-65
Kizu, R.; Hayakawa, K.; Miyazaki, M. 1989: HPLC determination of cis-diamminedichloroplatinum(II) in plasma and urine with UV detection and column-switching. Biomedical Chromatography: Bmc 3(1): 14-19
Hamann, J.A.; Johnson, K.; Jeter, D.T. 1985: HPLC determination of clenbuterol in pharmaceutical gel formulations. Journal of Chromatographic Science 23(1): 34-36
Yin, J.L. 1987: HPLC determination of clozapine in plasma. Zhonghua Shen Jing Jing Shen Ke Za Zhi 20(2): 78-80
Hulhoven, R.; Desager, J.P. 1977: HPLC determination of daunorubicin and daunorubicinol in human plasma. Biomedicine / 27(3): 102-104
Roberts, R.G. 1987: HPLC determination of ferrochelatase activity in human liver. Biomedical Chromatography: Bmc 2(2): 71-75
Krauss, J.S.; Khankhanian, N.K. 1989: HPLC determination of hemoglobin A1C in the presence of the fast hemoglobin I-Philadelphia. Clinical Chemistry 35(3): 494-495
Toupin, L.; Caillé, G.; Vézina, M.; Demontigny, C.; Tawashi, M. 1987: HPLC determination of indalpine and its major metabolite in human plasma and a pharmacokinetic application. Biopharmaceutics and Drug Disposition 8(6): 507-517
Ghittori, S.; Maestri, L.; Fiorentino, M.L.; Imbriani, M. 1988: HPLC determination of low concentrations of benzene. Giornale Italiano di Medicina del Lavoro 10(4-5): 201-205
Mazzacoratti, M.G.; Amado, D.; Cavalheiro, E.A. 1990: HPLC determination of norepinephrine, 5-hydroxytyramine and 5-hydroxytryptamine in rat brain using sodium dodecyl sulphate as ion-pair. Brazilian Journal of Medical and Biological Research 23(3-4): 255-262
Koshiishi, I.; Imanari, T. 1986: HPLC determination of orthophosphate coexisting with large amounts of organophosphates in biological samples. Biomedical Chromatography: Bmc 1(4): 169-172
Yun, Z.; Zhang, R.E. 1987: HPLC determination of polyamines in the femtomole range. Biomedical Chromatography: Bmc 2(4): 173-176
Prümke, H.J.; Lampe, D.; Hüller, H. 1987: HPLC determination of prednisolone and endogenous cortisol in the plasma of kidney transplant patients. Die Pharmazie 42(9): 632-633
Xue, L.; Zhang, S.R.; Yu, Y.W. 1989: HPLC determination of prostaglandins with small-bore ODS column. Yao Xue Xue Bao 24(4): 300-301
Galensa, R.; Ruhl, I. 1985: HPLC determination of sugar, mannitol and p-hydroxybenzoic acid esters in a syrup laxative for babies. Die Pharmazie 40(11): 805-806
Klimes, J.; Zahradnícek, M. 1987: HPLC determination of the carcinostatic Edikron in rat plasma. Die Pharmazie 42(10): 699
Geyer, R.; Fattal, F. 1987: HPLC determination of the metabolite 4-chloro-o-toluidine in the urine of workers occupationally exposed to chlordimeform. Journal of Analytical Toxicology 11(1): 24-26
Chen, Q.C.; Zhou, W.T.; Li, H.D. 1987: HPLC determination of the nikethamide concentration in plasma of 6 patients with chronic obstructive pulmonary disease. Zhongguo Yao Li Xue Bao 8(5): 413-416
Dittrich, P.; Ostrowski, J.; Beubler, E.; Schraven, E.; Kukovetz, W. 1985: HPLC determination of troxerutin in plasma and urine following oral administration in man. Arzneimittel-Forschung 35(4): 765-767
Nishimaki, S.; Sudo, J.; Tanabe, T. 1986: HPLC determination of "true" creatinine in rat plasma. Developments in Toxicology and Environmental Science 14: 251-254
Gaetani, E.; Laureri, C.F.; Vitto, M. 1987: HPLC determination with fluorimetry detection of morpholine, hydrazine and ammonia in aqueous solutions. Bollettino Chimico Farmaceutico 126(9): 365-367
Watanabe, N.; Toyo'oka, T.; Imai, K. 1987: HPLC electrochemical fluorometric detection of amino acids including tryptophan using 4-fluoro-7-nitrobenzo-2-oxa-1,3-diazole. Biomedical Chromatography: Bmc 2(3): 99-103
Dunn, B.P.; San, R.H. 1988: HPLC enrichment of hydrophobic DNA--carcinogen adducts for enhanced sensitivity of 32P-postlabeling analysis. Carcinogenesis 9(6): 1055-1060
Sha, Y. 1987: HPLC identification for guanxinsuhe pills. Zhong Yao Tong Bao 12(4): 40-41
Santucci, A.; Rustici, M.; Bracci, L.; Lozzi, L.; Soldani, P.; Neri, P. 1990: HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies. Journal of Immunological Methods 127(1): 131-138
Quercia, V.; Tucci, B.; Pierini, N.; Schreiber, L.; Biasci, R.; Caruso, P. 1979: HPLC in the identification and determination of irgasan DP 300 and hexachlorophene in cosmetic formulations. Bollettino Chimico Farmaceutico 118(12): 748-756
Fisher, T.S.; Vecsei, P.; Hoyer, G.A.; Lichtwald, K.; Kirk, D.N. 1986: HPLC isolation and GC-MS characterization of a compound strongly cross reacting with tetrahydroaldosterone antiserum. Journal of Steroid Biochemistry 25(1): 71-82
Flanagan, R.J.; Ruprah, M. 1989: HPLC measurement of chlorophenoxy herbicides, bromoxynil, and ioxynil, in biological specimens to aid diagnosis of acute poisoning. Clinical Chemistry 35(7): 1342-1347
Bhamra, R.K.; Ward, A.E.; Holt, D.W. 1987: HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma. Biomedical Chromatography: Bmc 2(4): 180-182
Flanagan, R.J.; Ward, N.M. 1986: HPLC measurement of meptazinol in plasma using electrochemical oxidation detection. Biomedical Chromatography: Bmc 1(4): 180-182
Walker, S.; Flanagan, R.J.; Holt, D.W. 1987: HPLC measurement of penticainide and desalkylpenticainide in biological fluids. Biomedical Chromatography: Bmc 2(1): 34-37
Grogan, W.M.; Huth, E.G. 1986: HPLC measurement of testicular long chain acyl-CoA synthetases with different substrate specificities. Lipids 21(1): 11-16
Gerlo, E.; Maes, V. 1988: HPLC method for assay of bamifylline in plasma from neonates. Clinical Chemistry 34(8): 1657
Zorz, M.; Culig, J.; Kopitar, Z.; Milivojević, D.; Marusic, A.; Bano, M. 1985: HPLC method for determination of ergot alkaloids and some derivatives in human plasma. Human Toxicology 4(6): 601-607
Kneifel, W.; Sommer, R. 1985: HPLC method for determination of vitamin C in milk, whey and whey beverages. Zeitschrift für Lebensmittel-Untersuchung und -Forschung 181(2): 107-110
Palma, F.; Ligi, F.; Soverchia, C.; Fioritti, A. 1991: HPLC method for measuring (Na(+)-K(+)) ATPase and (Ca(++)-Mg(++)) ATPase in erythrocytes from different species of mammals. Bollettino della Societa Italiana di Biologia Sperimentale 67(8): 759-766
Csallany, A.S.; Kindom, S.E.; Addis, P.B.; Lee, J.H. 1989: HPLC method for quantitation of cholesterol and four of its major oxidation products in muscle and liver tissues. Lipids 24(7): 645-651
Gaździk, W.R.; Podleśny, J.; Filipek, M. 1989: HPLC method for simultaneous determination of clobazam and N-desmethylclobazam in human serum, rat serum and rat brain homogenates. Biomedical Chromatography: Bmc 3(2): 79-81
Abbiati, G.A.; Restelli, G.; Graziani, G.; Testa, R. 1985: HPLC method for the determination of plasma and tissue levels of denzimol hydrochloride. Bollettino Chimico Farmaceutico 124(4): 178-185
Eigendorf, H.G. 1988: HPLC of 88 toxocologically relevant drugs in RP-column Separon SGX C 18. Die Pharmazie 43(4): 287-288
McCluer, R.H.; Ullman, M.D.; Jungalwala, F.B. 1986: HPLC of glycosphingolipids and phospholipids. Advances in Chromatography 25: 309-353
Lam, S.; Boselli, L. 1986: HPLC of trazodone in serum after microscale protein precipitation. Biomedical Chromatography: Bmc 1(4): 177-179
Crawford, G.A.; Györy, A.Z.; Gallery, E.D.; Kelly, D. 1990: HPLC of urinary catecholamines in the presence of labetalol, captopril, and alpha-methyldopa. Clinical Chemistry 36(10): 1849
Chen, G.; Griffin, M.; Poyer, J.L.; McCay, P.B. 1990: HPLC procedure for the pharmacokinetic study of the spin-trapping agent, alpha-phenyl-N-tert-butyl nitrone (PBN). Free Radical Biology and Medicine 9(2): 93-98
Nielsen, P.A.; Vahl, M.; Gry, J. 1988: HPLC profiles of mutagens in lean ground pork fried at different temperatures. Zeitschrift für Lebensmittel-Untersuchung und -Forschung 187(5): 451-456
Polo, F.; Ayuso, R.; Carreira, J. 1990: HPLC purification of the main allergen of Parietaria judaica pollen. Molecular Immunology 27(2): 151-157
Dianoux, A.C. 1986: HPLC purification of the natural ATPase inhibitor from the yeast Candida utilis. Biochemical and Biophysical Research Communications 134(1): 332-337
Jehl, F.; Monteil, H.; Tarral, A. 1988: HPLC quantitation of the six main components of teicoplanin in biological fluids. Journal of Antimicrobial ChemoTherapy 21 Suppl A: 53-59
Komoda, Y.; Chujo, H.; Ishihara, S.; Uchida, M. 1989: HPLC quantitative analysis of plantaginin in Shazenso (Plantago asiatica L.) extracts and isolation of plantamajoside. Iyo Kizai Kenkyujo Hokoku. Reports of the Institute for Medical and Dental Engineering Tokyo Medical and Dental University 23: 81-85
Desiderio, D.M.; Onishi, H.; Fridland, G.; Wood, G.; Pagidipati, D. 1987: HPLC receptorassay of opioid peptides in the cerebrospinal fluid of lower back pain patients. Biomedical Chromatography: Bmc 2(2): 47-52
Itabashi, Y.; Kukis, A.; Marai, L.; Takagi, T. 1990: HPLC resolution of diacylglycerol moieties of natural triacylglycerols on a chiral phase consisting of bonded (R)-(+)-1-(1-naphthyl)ethylamine. Journal of Lipid Research 31(9): 1711-1717
Ferguson, D.L.; Libson, K.; Zodda, J.P.; Heineman, W.R.; Deutsch, E. 1986: HPLC separated fractions of 99mTc(NaBH4)-HEDP as myocardial infarct imaging agents. International Journal of Radiation Applications and Instrumentation. Part A Applied Radiation and Isotopes 37(4): 341-344
Hu, L.Q.; Xu, D.Y. 1989: HPLC separation and characterization of chlorin derivatives with intact ring V from acid degradation products of silkworm excrement crude chlorophyll mixture. Biomedical Chromatography: Bmc 3(2): 72-74
Lecoq, S.; Pfau, W.; Grover, P.L.; Phillips, D.H. 1992: HPLC separation of 32P-postlabelled DNA adducts formed from dibenz[a,h]anthracene in skin. Chemico-Biological Interactions 85(2-3): 173-185
Pfau, W.; Hughes, N.C.; Grover, P.L.; Phillips, D.H. 1992: HPLC separation of 32P-postlabelled benzo[b]fluoranthene-DNA adducts. Cancer Letters 65(2): 159-167
Ragougy-Sengler, C.; Rolland, H.; Pileire, B. 1990: HPLC separation of alkaline phosphatase isoenzymes. Application to the amniotic fluid. Clinica Chimica Acta; International Journal of Clinical Chemistry 192(3): 207-211
Radeczky, G.; Szász, G.; Budváriné Bárány, Z. 1988: HPLC separation of amino acid enantiomers on reversed phase columns by means of L-asparaginic acid-alpha-butyl ester copper (II) complex. Acta Pharmaceutica Hungarica 58(6): 267-273
Thompson, M.A.; Lasley, B.L.; Barkley, M.S.; Czekala, N.M.; Monfort, S.L.; FitzGerald, R.C. 1985: HPLC separation of anti-estrogen and estrogen receptor binding components of mouse plasma. Steroids 46(1): 609-618
Bottomley, S.; Lovell-Smith, C.; Garcia-Webb, P. 1988: HPLC separation of corticosterone metabolites and its use in following corticosterone metabolism and transport in the isolated rat hepatocyte. Journal of Steroid Biochemistry 29(1): 145-148
Anonymous 1991: HPLC separation of human plasma catecholamines and their urinary metabolites. Liquid chromatographic separations. Journal of Chromatographic Science 29(10): 461
Choy, V.J.; Watkins, W.B. 1986: HPLC separation of vasopressin-like hormones in chicken neurohypophysial extracts. Neuropeptides 8(2): 183-191
Carrier, D.J.; Bogri, T.; Cosentino, G.P.; Guse, I.; Rakhit, S.; Singh, K. 1988: HPLC studies on leukotriene A4 obtained from the hydrolysis of its methyl ester. Prostaglandins Leukotrienes and Essential Fatty Acids 34(1): 27-30
Cook, A.P.; MacLeod, T.M.; Appleton, J.D.; Fell, A.F. 1989: HPLC studies on the degradation profiles of glucose 5% solutions subjected to heat sterilization in a microprocessor-controlled autoclave. Journal of Clinical Pharmacy and Therapeutics 14(3): 189-195
Jira, T.; Fleischmann, B.; Burghardt, G.; Beyrich, T.; Martin, E.; Kuhmstedt, H. 1985: HPLC studies on the distribution behavior of guanyl- and N-phenylguanylhydrazone derivatives. Die Pharmazie 40(1): 34-36
Vergnes, M.F.; Grosset, C.; Alary, J. 1988: HPLC study of potential metabolites of caffeine. Comparison of various techniques. Journal of Chromatography 455: 369-375
Smahi, Z.; Huvenne, J.P.; Traisnel, M. 1992: HPLC used in the validation of simple methods for research of degradation products in essential drug tablets. Annales Pharmaceutiques Francaises 50(3): 167-176
Svendsen, C.N.; Bird, E.D. 1986: HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain. Psychopharmacology 90(3): 316-321
Jehl, F.; Monteil, H.; Gallion, C.; Thierry, R.C. 1985: HPLC, RIA, FPIA. Evaluation of 3 methods for the assay of vancomycin. Pathologie-Biologie 33(5 Part 2): 511-516
Watson, W.P.; Crane, A.E. 1989: HPLC-32P-postlabelling analysis of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine. Mutagenesis 4(1): 75-77
Sharp, T.; Zetterström, T.; Series, H.G.; Carlsson, A.; Grahame-Smith, D.G.; Ungerstedt, U. 1987: HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life Sciences 41(7): 869-872
Roettger, V.R.; Goldfinger, M.D. 1991: HPLC-EC determination of free primary amino acid concentrations in cat cisternal cerebrospinal fluid. Journal of Neuroscience Methods 39(3): 263-270
Shibanoki, S.; Weinberger, S.B.; Ishikawa, K.; Martinez, J.L. 1990: HPLC-ECD determination of the enzymatic hydrolysis of [leu]- and [met]enkephalin in rat plasma. Progress in Clinical and Biological Research 328: 253-256
Reid, J.J.; Stitzel, R.E.; Head, R.J. 1985: HPLC-ECD procedure for the measurement of O-methylation of catechol estrogens by vascular tissue. Journal of Pharmacological Methods 14(1): 25-39
Valentine, J.L.; Bryant, P.J.; Gutshall, P.L.; Gan, O.H.; Thompson, E.D.; Niu, H.C. 1976: HPLC-MS determination of delta9-tetrahydrocannabiol in human body samples. Nida Research Monograph 7: 96-106
Brockmöller, J.; Simane, Z.J.; Roots, I. 1988: HPLC-analysis of S-carboxymethylcysteine and its sulphoxide metabolites. Drug Metabolism and Drug Interactions 6(3-4): 447-456
Rollema, H.; Fries, D.S.; de Vries, J.B.; Mastebroek, D.; Horn, A.S. 1985: HPLC-assay with electrochemical detection for the neurotoxin MPTP, its metabolite MPP+ and MPTP-analogues in biological samples after purification over Sephadex G10. Life Sciences 37(17): 1633-1640
Retzios, A.D.; Markland, F.S. 1990: HPLC-based two-step purification of fibrinolytic enzymes from the venom of Agkistrodon contortrix contortrix and Agkistrodon piscivorus conanti. Protein Expression and Purification 1(1): 33-39
Noe, A.; Kunze, P. 1989: HPLC-determination of apomorphine in a mormyrid fish, gnathonemus petersii. Zeitschrift für Naturforschung. C Journal of Biosciences 44(11-12): 917-919
Przyborowski, L.; Misztal, G. 1991: HPLC-determination of trifluperidol in blood plasma. Die Pharmazie 46(11): 813-814
Iwamoto, T.; Yoshiura, M.; Iriyama, K. 1988: HPLC-electrochemical detection method. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 33(3): 252-257
Szász, G.; Budváriné-Bárány, Z.; Löre, A.; Kökösi, J.; Orfi, L. 1991: HPLC-investigations of imidazoquinazolone derivatives. Part 2. Acta Pharmaceutica Hungarica 61(2): 91-97
Teichert, J.; Preiss, R. 1992: HPLC-methods for determination of lipoic acid and its reduced form in human plasma. International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 511-512
Belfi, C.A.; Box, H.C. 1985: HPLC-n.m.r. studies of radiation damage to d(TpA). International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 47(4): 393-396
Uchiyama, S.; Ishizaka, T.; Saito, Y.; Furuya, T.; Sekita, K.; Tobe, M. 1985: HPLC-pattern change of emetic ogonori (Gracilaria verrucosa Papenf.) components treated by an artificial gastric juice. Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 103: 97-101
Bachman, W.J.; Stewart, J.T. 1990: HPLC-photolysis-electrochemical detection in pharmaceutical analysis: application to the determination of spironolactone and hydrochlorothiazide in tablets. Journal of Chromatographic Science 28(3): 123-128
Niles, L.P.; Pickering, D.S.; Sayer, B.G. 1987: HPLC-purified 2-[125I]iodomelatonin labels multiple binding sites in hamster brain. Biochemical and Biophysical Research Communications 147(3): 949-956
Bellinger, L.L.; Mendel, V.E. 1991: HPLC-purified human satietin does not produce conditioned taste aversion in rats. Pharmacology Biochemistry and Behavior 39(1): 161-165
Sogami, M.; Era, S.; Nagaoka, S.; Kuwata, K.; Kida, K.; Miura, K.; Inouye, H.; Suzuki, E.; Hayano, S.; Sawada, S. 1985: HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. International Journal of Peptide and Protein Research 25(4): 398-402
Sharp, J.W.; Roncagli, T. 1992: HPN in advanced malignancies. Jpen. Journal of Parenteral and Enteral Nutrition 16(2): 190-191
Kosugi, I. 1979: Medical mass-spectrometer for blood and tissue gas analysis. Kokyu to Junkan. Respiration and Circulation 27(8): 849-853
Arends, J.; Davidson, C.L. 1975: HPO2-4 content in enamel and artificial carious lesions. Calcified Tissue Research 18(1): 65-79
Fujimori, S.; Yamanouchi, T.; Akaoka, I. 1991: HPRT deficiency. Nihon Rinsho. Japanese Journal of Clinical Medicine 49(5): 1036-1042
Guillouf, C.; Moustacchi, E.; Papadopoulo, D. 1991: HPRT gene expression differs in mutants derived from normal and Fanconi anemia cells: analysis of spontaneous and psoralen-photoinduced mutants. Somatic Cell and Molecular Genetics 17(6): 591-599
Ogasawara, N.; Yamada, Y.; Goto, H. 1991: HPRT gene mutations in a female Lesch-Nyhan patient. Advances in Experimental Medicine and Biology 309b: 109-112
Melton, D.W. 1987: HPRT gene organization and expression. Oxford Surveys on Eukaryotic Genes 4: 34-76
Gordon, R.B.; Keough, D.T.; Emmerson, B.T. 1987: HPRT-deficiency associated with normal PRPP concentration and APRT activity. Journal of Inherited Metabolic Disease 10(1): 82-88
Degnen, G.E.; Miller, I.L.; Adelberg, E.A.; Eisenstadt, J.M. 1977: HPRTase expression in mouse gene transferents. Brookhaven Symposia in Biology 29: 135-146
Zhang, Q.; Li, S.; Cheng, J.; Yan, K.; Tian, S. 1990: HPTLC densitometric determination of free bile acids in bezoar. Zhongguo Zhong Yao Za Zhi 15(6): 360
Gardyan, C.; Thier, H.P. 1992: HPTLC for the confirmation of results in the analysis of pesticide residues. Zeitschrift für Lebensmittel-Untersuchung und -Forschung 194(4): 344-350
Hørding, U.; Daugaard, S.; Bock, J.E.; Sebbelov, A.M.; Norrild, B. 1991: HPV 11, 16 and 18 DNA sequences in cervical swabs from women with cervical dysplasia: prevalence and associated risk of progression. European Journal of Obstetrics Gynecology and Reproductive Biology 40(1): 43-48
Rüdlinger, R.; Buchmann, P. 1989: HPV 16-positive bowenoid papulosis and squamous-cell carcinoma of the anus in an HIV-positive man. Diseases of the Colon and Rectum 32(12): 1042-1045
Scinicariello, F.; Rady, P.; Cloyd, M.W.; Tyring, S.K. 1991: HPV 18 in HIV-associated Kaposi's sarcoma. Lancet 337(8739): 501
Nuovo, G.J. 1989: HPV DNA detection in cervical swabs. Human Pathology 20(10): 1030
Della Torre, G.; Donghi, R.; Longoni, A.; Pilotti, S.; Pasquini, G.; De Palo, G.; Pierotti, M.A.; Rilke, F.; Della Porta, G. 1992: HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 1(1): 25-30
Duggan, M.A.; Lim, M.; Gill, M.J.; Inoue, M. 1990: HPV DNA typing of adult-onset respiratory papillomatosis. Laryngoscope 100(6): 639-642
Vd Berg, V.D.; Bots, T.C. 1989: HPV and cervical cancer. Human Pathology 20(8): 817-818
Muñoz, N.; Bosch, F.X. 1992: HPV and cervical neoplasia: review of case-control and cohort studies. Iarc Scientific Publications 119: 251-261
Husseinzadeh, N.; DeEulis, T.; Newman, N.; Wesseler, T. 1991: HPV changes and their significance in patients with invasive squamous cell carcinoma of the vulva: a clinicopathologic study. Gynecologic Oncology 43(3): 237-241
Johnson, T.L.; Plieth, D.A.; Crissman, J.D.; Sarkar, F.H. 1991: HPV detection by polymerase chain reaction (PCR) in verrucous lesions of the upper aerodigestive tract. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 4(4): 461-465
Gitsch, G.; Wirnsberger, G.; Reinthaller, A.; Neunteufel, W.; Tatra, G.; Breitenecker, G. 1990: HPV detection in tissue and smear of cervix dysplasia by in situ hybridization. Gynakologische Rundschau 30(Suppl 1): 160-162
Syrjänen, K.; Yliskoski, M. 1992: HPV follow-up research in Kuopio City. Katilolehti 97(5): 13-15
Cooper, K.; McGee, J.O. 1992: HPV genotypes in cervical neoplasia in South Africa. Journal of Clinical Pathology 45(1): 90
Garrido, J.L. 1988: HPV incidence in the Republic of Panama in 1985. European Journal of Gynaecological Oncology 9(5): 390-395
Wartusch, B.; Heim, K.; Weiss, D.; Müller-Holzner, E.; Holböck, E.; Pinzger, G. 1990: HPV infection and cytology in follow-up of laser therapy of condylomata. Gynakologische Rundschau 30(Suppl 1): 157-160
Heim, K.; Pinzger, G.; Wartusch, B.; Müller-Holzner, E.; Holböck, E.; Zeimet, A.; Baumgartner, P.; Höpfl, R.; Weiss, D.; Ruth, N.R. 1992: HPV infection in the area of the vulva. Gynakologisch-Geburtshilfliche Rundschau 32(Suppl 1): 21-25
Pungetti, D.; Calderara, M.A.; Vicini, G.; Selleri, M.C.; Spadaro, F.; Zanardi, E. 1991: HPV infections in the lower genital tract in the female. Results of beta-interferon treatment. Minerva Ginecologica 43(10): 469-474
Milde-Langosch, K.M.; Löning, T.; Meichsner, M.; Henke, R.P. 1989: HPV infections in tumors of the upper respiratory and digestive tract. in situ hybridization and dot-blot hybridization with biotinylated DNA probes. Acta Histochemica. Supplementband 37: 103-108
Ronalds, C.J. 1990: HPV or human parvovirus?. Journal of Clinical Pathology 43(5): 438
Bistoletti, P. 1989: HPV screening is not ethically justified. Lakartidningen 86(16): 1463
De Sanjosé, S.; Santamaria, M.; Alonso de Ruiz, P.; Aristizabal, N.; Guerrero, E.; Castellsagué, X.; Bosch, F.X. 1992: HPV types in women with normal cervical cytology. Iarc Scientific Publications 119: 75-84
Ghim, S.J.; Jenson, A.B.; Schlegel, R. 1992: HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology 190(1): 548-552
Banks, L.; Barnett, S.C.; Crook, T. 1990: HPV-16 E7 functions at the G1 to S phase transition in the cell cycle. Oncogene 5(6): 833-837
Crook, T.; Farthing, A.; Vousden, K. 1992: HPV-16 and cervical intraepithelial neoplasia. Lancet 339(8803): 1231
Park, J.S.; Rader, J.S.; Wu, T.C.; Laimins, L.A.; Currie, J.L.; Kurman, R.J.; Shah, K.V. 1991: HPV-16 viral transcripts in vulvar neoplasia: preliminary studies. Gynecologic Oncology 42(3): 250-255
Hauser, B.; Gross, G.; Schneider, A.; de Villiers, E.M.; Gissmann, L.; Wagner, D. 1985: HPV-16-related Bowenoid papulosis. Lancet 2(8446): 106
Huang, Y.Q.; Li, J.J.; Rush, M.G.; Poiesz, B.J.; Nicolaides, A.; Jacobson, M.; Zhang, W.G.; Coutavas, E.; Abbott, M.A.; Friedman-Kien, A.E. 1992: HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 339(8792): 515-518
Kaur, P.; McDougall, J.K. 1989: HPV-18 immortalization of human keratinocytes. Virology 173(1): 302-310
Wätzig, V.; Jablonská, S. 1987: HPV-20-induced epidermodysplasia verruciformis. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(9): 521-524
Obalek, S.; Jablonska, S.; Orth, G. 1985: HPV-associated intraepithelial neoplasia of external genitalia. Clinics in Dermatology 3(4): 104-113
Ferenczy, A. 1989: HPV-associated lesions in pregnancy and their clinical implications. Clinical Obstetrics and Gynecology 32(1): 191-199
Reid, R.; Campion, M.J. 1989: HPV-associated lesions of the cervix: biology and colposcopic features. Clinical Obstetrics and Gynecology 32(1): 157-179
Massone, L.; Anonide, A.; Pestarino, A.; Solari, G.; Priano, L.; Isola, V. 1990: HPV-induced subclinical lesions of the male genitalia. use of a colposcope. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 125(5): 183-186
Aloi, F.; Tomasini, C.; Pippione, M. 1992: HPV-related follicular cysts. American Journal of Dermatopathology 14(1): 37-41
Barrasso, R. 1992: HPV-related genital lesions in men. Iarc Scientific Publications 119: 85-92
Herrington, C.S.; Evans, M.F.; Gray, W.; McGee, J.O.; Hallam, N.; Charnock, F.M. 1992: HPV16 DNA and prediction of high-grade CIN. Lancet 339(8805): 1352-1353
Tommasino, M.; Contorni, M.; Cavalieri, F. 1992: HPV16 E7 phosphorylation in fission yeast: characterization and biological effects. Gene 111(1): 93-98
Yasumoto, S. 1989: HPV16 participates in progressive transformation of normal epidermal cells. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 2): 549-561
Felmar, E. 1991: HPV: what should family physicians do?. American Family Physician 43(4): 1217-1218
Vadeboncoeur, C.; Konishi, Y.; Dumas, F.; Gauthier, L.; Frenette, M. 1991: HPr polymorphism in oral streptococci is caused by the partial removal of the N-terminal methionine. Biochimie 73(11): 1427-1430
Sutrina, S.L.; Waygood, E.B.; Grenier, F.C.; Saier, M.H. 1987: HPr/HPr-P phosphoryl exchange reaction catalyzed by the mannitol specific enzyme Ii of the bacterial phosphotransferase system. Journal of Biological Chemistry 262(6): 2636-2641
Su, T.P. 1986: HR 375: a potential antipsychotic drug that interacts with dopamine D2 receptors and sigma-receptors in the brain. Neuroscience Letters 71(2): 224-228
Neu, H.C.; Aswapokee, N.; Aswapokee, P.; Fu, K.P. 1979: HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 15(2): 273-281
Dainelli, B.; Filadoro, F.; Magni, A.; Maragoni, F.; Renzini, G. 1979: HR 756. in vitro microbiological activity against various species of anaerobic bacteria. Giornale Italiano di Chemioterapia 26(1-2): 141-144
Chantot, J.F.; Bryskier, A. 1985: HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin. Pathologie-Biologie 33(5 Part 2): 482-486
Clarke, A.M.; Zemcov, S.J.; Wright, J.M. 1985: HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity: an in-vitro comparison with other beta-lactam antibiotics. Journal of Antimicrobial ChemoTherapy 15(3): 305-310
Kosteva, D.B. 1988: HR professionals: get close to the "gods". Hospitals 62(5): 88
Ferraro, S.; Santomauro, M.; Maddalena, G.; D'Agosto, V.; Romano, M.; Fazio, S.; Chiariello, M. 1990: HR/QT ratio during ergometric test: influence of ischemia and beta blocking therapy. Cardiologia 35(9): 741-746
Morris, C.M.; Fitzgerald, P.H.; Kennedy, M.A.; Hollings, P.E.; Garry, M.; Corbett, G.M. 1989: HRAS1 and INS genes are relocated but not structurally altered as a result of the t(7;11)(p15;p15) in a clone from a patient with acute myeloid leukaemia (M4). British Journal of Haematology 71(4): 481-486
Radice, P.; Pierotti, M.A.; Borrello, M.G.; Illeni, M.T.; Rovini, D.; Della Porta, G. 1987: HRAS1 proto-oncogene polymorphisms in human malignant melanoma: Taqi defined alleles significantly associated with the disease. Oncogene 2(1): 91-95
Porteous, D.J.; Bickmore, W.; Christie, S.; Boyd, P.A.; Cranston, G.; Fletcher, J.M.; Gosden, J.R.; Rout, D.; Seawright, A.; Simola, K.O. 1987: HRAS1-selected chromosome transfer generates markers that colocalize aniridia- and genitourinary dysplasia-associated translocation breakpoints and the Wilms tumor gene within band 11p13. Proceedings of the National Academy of Sciences of the United States of America 84(15): 5355-5359
Gosden, J.R.; Porteous, D.J. 1987: HRAS1-selected, chromosome mediated gene transfer; in situ hybridization with combined biotin and tritium label localizes the oncogene and reveals duplications of the human transgenome. Cytogenetics and Cell Genetics 45(1): 44-51
Porteous, D.J.; Morten, J.E.; Foster, M.E.; Cranston, G.; Weir-Thompson, E.; Busuttil, A.; Bobstock, C.J.; Steel, C.M. 1986: HRAS1-selected, chromosome-mediated transformants vary in phenotype in vitro and tumorigenic potential in vivo. International Journal of Cancer 38(4): 603-612
Nakamura, S.; Sawamura, S. 1978: HRC adjustable pneumatic swing-phase control knee. Prosthetics and Orthotics International 2(3): 137-142
Brès, E.F.; Hutchison, J.L.; Senger, B.; Voegel, J.C.; Frank, R.M. 1991: HREM study of irradiation damage in human dental enamel crystals. Ultramicroscopy 35(3-4): 305-322
Okada, H.; Okada, N.; Hideshima, T. 1990: HRF20, a membrane inhibitor of complement attack, does not protect cells from the cytotoxic reaction by lymphokine activated killer cells. Biochemical and Biophysical Research Communications 171(2): 717-721
Brooks, D.A.; Dean, R.S.; Gray, J.W. 1989: HRNB factors with simultaneous-successive marker variables. International Journal of Neuroscience 46(3-4): 157-160
Burke, R.E.; Walmsley, B.; Hodgson, J.A. 1979: HRP anatomy of group Ia afferent contacts on alpha motoneurones. Brain Research 160(2): 347-352
Corbett, M.D.; Corbett, B.R. 1987: HRP-catalyzed bioactivation of carcinogenic hydroxamic acids. the greater reactivity of glycolyl- versus acetyl-derived hydroxamic acids. Chemico-Biological Interactions 63(3): 249-264
Freire, M. 1990: HRP-filling of neurons and axonal arbors in fixed brain slabs. Journal of Neuroscience Methods 35(3): 267-275
Chen, K.N.; Wen, C.Y.; Shieh, J.Y. 1989: HRP-labeled masticatory neurons in the rat trigeminal mesencephalic nucleus: a light and electron microscopic study. Proceedings of the National Science Council Republic of China. Part B Life Sciences 13(4): 298-306
Danis, R.P.; Wallow, I.H. 1986: HRP/trypsin technique for studies of the retinal vasculature. Investigative Ophthalmology and Visual Science 27(3): 434-437
Matheny, S.C.; Kilpatrick, N.S. 1988: HRSA AIDS curriculum conferences assist primary care health professionals. Public Health Reports 103(5): 553-556
Crane, A.B. 1991: HRSA's collaborative efforts with national organizations to expand primary care for the medically underserved. Public Health Reports 106(1): 10-14
Harmon, R.G.; Carlson, R.H. 1991: HRSA's role in primary care and public health in the 1990s. Public Health Reports 106(1): 6-10
Johnson, D.; Clark, S. 1992: HRT and audit circles. Practitioner 236(1514): 566-569
Compston, J.E. 1992: HRT and osteoporosis. British Medical Bulletin 48(2): 309-344
Wren, B.G. 1992: HRT and the cardiovascular system. Australian Family Physician 21(3): 226-229
Fairlie, J. 1989: HRT and the menopause. Health Visitor 62(10): 321
Burke, E.; Cecil, J. 1991: HRT clinics. Practitioner 235(1507): 747-751
Downes, E. 1992: HRT: Non-compliance and education. British Journal of Hospital Medicine 48(5): 265
Herkimer, A.G.; Eberhard, M.J.; Pollard, J.L.; Uhl, K.L.; Zaretsky, H.W. 1977: HRU: a standard measurement for hospital productivity. Topics in Health Care Financing 4(2): 29-36
Toki, S.; Morishita, Y.; Sano, T.; Matsuda, Y. 1992: HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells. Neuroscience Letters 135(1): 117-120
Morishita, Y.; Sano, T.; Kase, H.; Yamada, K.; Inagami, T.; Matsuda, Y. 1992: HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors. European Journal of Pharmacology 225(3): 203-207
Sano, T.; Imura, R.; Morishita, Y.; Matsuda, Y.; Yamada, K. 1992: HS-142-1, a novel polysaccharide of microbial origin, specifically recognizes guanylyl cyclase-linked ANP receptor in rat glomeruli. Life Sciences 51(18): 1445-1451
Whiteman, J.R. 1977: HSA councils meet to study health care. Journal of the Missouri Dental Association 57(8): 35-36
Sims, R.L.; Handel, D.J. 1979: HSA fosters hospitals' voluntary cooperation in areawide planning. Hospitals 53(18): 95-97
Horty, J.F. 1979: HSA must abide by its own rules, court says. Modern Healthcare 9(4): 70-71
Greene, J.C. 1977: HSA's and all that. a solution?. Journal of the Michigan Dental Association 59(9): 494-496; 498-500
MacLean, G.A. 1978: HSA--challenge and an opportunity. Cds Review 71(1): 23
Rothenberg, E.; Schimel, D. 1977: HSA/PSRO relationships. Journal of Legal Medicine 5(11): 24-26
Cohn, S.L. 1979: HSAs are arenas of conflict; physicians are essential to success. Michigan Medicine 78(8): 126
Traska, M.R. 1977: Emission scanning units 'steal' the nuclear show. Modern Healthcare 7(8): 40-41
Simler, S.L. 1979: HSAs misuse draft CON checklist. Modern Healthcare 9(11): 30
DiPaolo, V. 1978: Nonprofits predict 38% rise in contract business. Modern Healthcare 8(4): 47; 50
Traska, M.R. 1979: HSAs to scrutinize Con applications for equipment. Modern Healthcare 9(1): 44; 46
Kuntz, E. 1979: HSAs will concentrate on plan implementation. Modern Healthcare 9(11): 51-52
Edelman, J. 1976: HSAs: a way out of the regulatory mess?. Trustee: the Journal for Hospital Governing Boards 29(4): 7-8
Amitsur, M.; Morad, I.; Chapman-Shimshoni, D.; Kaufmann, G. 1992: HSD restriction-modification proteins partake in latent anticodon nuclease. EMBO Journal 11(8): 3129-3134
Aho, C. 1992: HSDM's five-year plan. Shaping the future of dentistry. Harvard Dental Bulletin 2(1): 7-8
Engler, H.D.; Kapral, F.A. 1992: The production of a bactericidal monoglyceride in staphylococcal abscesses. Journal of Medical Microbiology 37(4): 238-244
Nover, L. 1991: HSFs and HSPs--a stressful program on transcription factors and chaperones. Stress Proteins and the Heat Shock Response, sponsored by Cold Spring Harbor Laboratory, Cold Spring Harbor, NY USA, April 29-May 2, 1991. New Biologist 3(9): 855-859
Facchini, G.; Filippi, G.; Zaccheo, F.; Nannetti, M. 1987: HSGC as an alternative to traditional gas chromatography in analysis of natural flavors fixed on solid supports. Bollettino Chimico Farmaceutico 126(8): 326-329
Starck, L. 1979: HSL (Health and Nursing Teachers' Organization) dissolved. Tidskrift for Sjukvardspedagoger 26(5-6): 8
Weinkauf, D.J.; Scully, H.E. 1989: HSOs: Ontario's answer to HMOs?. Cmaj: Canadian Medical Association Journal 140(5): 515-519
Rollet, E.; Best-Belpomme, M. 1986: HSP 26 and 27 are phosphorylated in response to heat shock and ecdysterone in Drosophila melanogaster cells. Biochemical and Biophysical Research Communications 141(2): 426-433
Sanchez, Y.; Lindquist, S.L. 1990: HSP104 required for induced thermotolerance. Science 248(4959): 1112-1115
Praekelt, U.M.; Meacock, P.A. 1990: HSP12, a new small heat shock gene of Saccharomyces cerevisiae: analysis of structure, regulation and function. Molecular and General Genetics: Mgg 223(1): 97-106
Hirayoshi, K.; Kudo, H.; Takechi, H.; Nakai, A.; Iwamatsu, A.; Yamada, K.M.; Nagata, K. 1991: HSP47: a tissue-specific, transformation-sensitive, collagen-binding heat shock protein of chicken embryo fibroblasts. Molecular and Cellular Biology 11(8): 4036-4044
Salo, D.C.; Donovan, C.M.; Davies, K.J. 1991: HSP70 and other possible heat shock or oxidative stress proteins are induced in skeletal muscle, heart, and liver during exercise. Free Radical Biology and Medicine 11(3): 239-246
Karasev, A.V.; Kashina, A.S.; Gelfand, V.I.; Dolja, V.V. 1992: HSP70-related 65 kDa protein of beet yellows closterovirus is a microtubule-binding protein. Febs Letters 304(1): 12-14
Guerriero, V.; Raynes, D.A.; Gutierrez, J.A. 1989: HSP70-related proteins in bovine skeletal muscle. Journal of Cellular Physiology 140(3): 471-477
Anderson, J.; Murphy, N.C. 1986: HSPQ in learning disability assessment. Journal of Learning Disabilities 19(7): 408-410
Olson, M. 1985: Organization and financing of medical care. Medical Care 23(5): 432-437
LaVail, J.H.; Zhan, J.; Margolis, T.P. 1990: HSV (type 1) infection of the trigeminal complex. Brain Research 514(2): 181-188
Holbach, L.M.; Font, R.L.; Baehr, W.; Pittler, S.J. 1991: HSV antigens and HSV DNA in avascular and vascularized lesions of human herpes simplex keratitis. Current Eye Research 10 Suppl: 63-68
Lehtinen, M. 1986: HSV infected RAJI-cells specify HSV specific immediate early and/or early DNA-binding proteins. Archives of Virology 87(1-2): 107-118
Matz, B.; Schlehofer, J.R.; Zur Hausen, H.; Huber, B.; Fanning, E. 1985: HSV- and chemical carcinogen-induced amplification of SV40 DNA sequences in transformed cells is cell-line-dependent. International Journal of Cancer 35(4): 521-525
Ben-Hur, T.; Rösen-Wolff, A.; Lamade, W.; Darai, G.; Becker, Y. 1988: HSV-1 DNA sequence determining intraperitoneal pathogenicity in mice is required for transcription of viral immediate-early genes in macrophages. Virology 163(2): 397-404
Gordon, Y.J.; Romanowski, E.; Araullo-Cruz, T.; McKnight, J.L. 1991: HSV-1 corneal latency. Investigative Ophthalmology and Visual Science 32(3): 663-665
Levy, R.B.; Jones, M.; Cray, C. 1990: HSV-1 enhances GvHR-associated parent anti-F1 alloreactivity in vivo and in vitro. Cellular Immunology 129(1): 1-12
Kühn, J.E.; Klaffke, K.; Munk, K.; Braun, R.W. 1990: HSV-1 gB and VZV gp-Ii crossreactive antibodies in human sera. Archives of Virology 112(3-4): 203-213
Lindemann, R.A.; Golub, S.H.; Park, N.H. 1987: HSV-1 infected oral epithelial cells are targets for natural killer cells. Advances in Experimental Medicine and Biology 216a: 543-551
Litwińska, B.; Sadowski, W.; Kańtoch, M. 1987: HSV-1 infection and immunity in immunosuppressed mice. Acta Virologica 31(4): 298-306
Gordon, Y.J.; Caudill, J.W.; Romanowski, E.; Araullo-Cruz, T. 1987: HSV-1 latency: thymidine kinase requirement and the round-trip theory. Current Eye Research 6(4): 611-616
Shimomura, Y.; Dudley, J.B.; Gangarosa, L.P.; Hill, J.M. 1985: HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation. Investigative Ophthalmology and Visual Science 26(1): 121-125
Yamamoto, Y.; Hill, J.M. 1986: HSV-1 recovery from ocular tissues after viral inoculation into the superior cervical ganglion. Investigative Ophthalmology and Visual Science 27(10): 1447-1452
Kielty, D.; Cousins, S.W.; Atherton, S.S. 1987: HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice. Investigative Ophthalmology and Visual Science 28(12): 1994-1999
Gordon, Y.J.; Lance, S.; Ricardi, T.; Romanowski, E.; Araullo-Cruz, T. 1987: HSV-1 thymidine kinase negative vaccine: pathogenicity, protection, and perils. Current Eye Research 6(1): 151-159
Freese, A.; Geller, A.I.; Neve, R. 1990: HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology. Biochemical Pharmacology 40(10): 2189-2199
Ben-Hur, T.; Asher, Y.; Tabor, E.; Darai, G.; Becker, Y. 1987: HSV-1 virulence for mice by the intracerebral route is encoded by the BamHI-L DNA fragment containing the cell fusion gene. Archives of Virology 96(1-2): 117-122
Rong, B.L.; Libermann, T.A.; Kogawa, K.; Ghosh, S.; Cao, L.X.; Pavan-Langston, D.; Dunkel, E.C. 1992: HSV-1-inducible proteins bind to NF-kappa B-like sites in the HSV-1 genome. Virology 189(2): 750-756
Lindemann, R.A.; Golub, S.H.; Park, N.H. 1987: HSV-1-infected oral epithelial cells are targets for natural killer cells. Journal of Dental Research 66(3): 770-773
Carbary, L.J. 1976: HSV-2 (newest VD menace). Nursing Care 9(6): 22-24
Hamasaki, D.I.; Atherton, S.S.; Dix, R.D. 1990: HSV-2 alters retinal physiology and morphology bilaterally in mice. Investigative Ophthalmology and Visual Science 31(6): 1056-1069
Boddingius, J.; Dijkman, H.; Hendriksen, E.; Schift, R.; Stolz, E. 1987: HSV-2 replication sites, monocyte and lymphocytic cell infection and virion phagocytosis by neutrophils, in vesicular lesions on penile skin. Electronoptical studies of a biopsy. Journal of Cutaneous Pathology 14(3): 165-175
DiPaolo, J.A.; Woodworth, C.D.; Popescu, N.C.; Koval, D.L.; Lopez, J.V.; Doniger, J. 1990: HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes. Virology 177(2): 777-779
Gupta, M.M.; Jain, R.; Parashari, A.; Singh, V.; Satyanarayana, L. 1992: HSV-IgA serum antibodies in cervical intraepithelial neoplasia and invasive cancer patients, and in their spouses: a case control study. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 100(7): 598-604
Epstein, R.J.; Kindle, J.C.; Stulting, R.D. 1987: HSV-induced blastogenesis in splenic mononuclear cells from inbred mice. Current Eye Research 6(1): 145-150
Dunkel, E.C.; Pavan-Langston, D. 1987: HSV-induced reactivation: contribution of epinephrine after corneal iontophoresis. Current Eye Research 6(1): 75-84
Malaty, R.; Gebhardt, B.M.; Franklin, R.M. 1988: HSV-specific IgA from tears blocks virus attachment to the cell membrane. Current Eye Research 7(3): 313-320
Veerisetty, V.; Gentry, G.A. 1985: HSV1-specific thymidylate kinase activity in infected cells. Intervirology 24(1): 42-49
Puligheddu, P.; Nieddu, R.; Medda, F.; Marcello, C.; Lecca, U. 1988: HSV2 and cervical intraepithelial neoplasia: cytological, histological and serological features. Clinical and Experimental Obstetrics and Gynecology 15(3): 88-93
Superti, F.; Tinari, A.; Baldassarri, L.; Donelli, G. 1991: HT-29 cells: a new substrate for rotavirus growth. Archives of Virology 116(1-4): 159-173
Zwelling, L.A.; Slovak, M.L.; Doroshow, J.H.; Hinds, M.; Chan, D.; Parker, E.; Mayes, J.; Sie, K.L.; Meltzer, P.S.; Trent, J.M. 1990: HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase Ii. Journal of the National Cancer Institute 82(19): 1553-1561
Zhang, Y.; Babin, J.; Feldhaus, A.L.; Singh, H.; Sharp, P.A.; Bina, M. 1991: HTF4: a new human helix-loop-helix protein. Nucleic Acids Research 19(16): 4555
Gubernatis, G.; Pichlmayr, R.; Lamesch, P.; Grosse, H.; Bornscheuer, A.; Meyer, H.J.; Ringe, B.; Farle, M.; Bretschneider, H.J. 1990: HTK-solution (Bretschneider) for human liver transplantation. first clinical experiences. Langenbecks Archiv für Chirurgie 375(2): 66-70
Somerfield, S.D. 1986: HTLV 1 induced adult T cell leukaemia in New Zealand. New Zealand Medical Journal 99(802): 384
James, J.J.; Morgenstern, M.; Hatten, J.A.; Koch, M.A. 1986: HTLV IIi and hepatitis a and B serological markers among U.S. military venereal disease patients. Military Medicine 151(4): 193-198
Seifried, E.; Pindur, G.; Stötter, H.; Porzsolt, F.; Rasche, H.; Erfle, V.; Hehlmann, R.; Heimpel, H. 1986: HTLV IIi antibodies and immunological alterations in hemophilia patients. Klinische Wochenschrift 64(3): 115-124
Bingham, J.S. 1985: HTLV IIi infection and AIDS. Practitioner 229(1408): 869-875
Kimmel, K. 1986: HTLV III/LAV (AIDS)-infection protection. Quintessenz Journal 16(7): 695-698
Stankaitis, J.A.; Bigos, J.P. 1987: HTLV III/LAV screening and blood banking. American Journal of Public Health 77(2): 239
Wachsman, W.; Golde, D.W.; Chen, I.S. 1986: HTLV and human leukemia: perspectives 1986. Seminars in Hematology 23(4): 245-256
Varmier, O.; Melioli, G.; Lillo, F.; Schito, G.; Repetto, C.; Ravegnani, M.; Battaglia, M. 1987: HTLV antibodies in Italian patients with multiple sclerosis. Italian Journal of Neurological Sciences Suppl 6: 51-52
Blomberg, J.; Nilsson, I.; Kjellén, L. 1985: HTLV in Sweden: antibodies to HTLV i antigens in experimental monkeys and their caretakers. Scandinavian Journal of Infectious Diseases 17(2): 135-139
Page, J.B.; Lai, S.; Chitwood, D.D. 1990: HTLV increases HIV risk. Nursing Times 86(26): 10
Yukimichi, H.; Hayamizu, M. 1987: HTLV infection in patients with bone marrow transplantation. Japanese Journal of Clinical Hematology 28(10): 1892-1893
Anzèn, B.; Lidman, K. 1987: HTLV infections in women--a review. Lakartidningen 84(32-33): 2486-2490
Hunsmann, G.; Schneider, J.; Wendler, I.; Fleming, A.F. 1985: HTLV positivity in Africans. Lancet 2(8461): 952-953
Goubau, P.; Carton, H.; Kazadi, K.; Muya, K.W.; Desmyter, J. 1990: HTLV seroepidemiology in a central African population with high incidence of tropical spastic paraparesis. Transactions of the Royal Society of Tropical Medicine and Hygiene 84(4): 577-579
Varnier, O.E.; Lillo, F.; Alexander, S.S.; Forbis, R.M.; Present, W.; Lazzarin, A. 1991: HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-Ii infection. JAMA 265(5): 597
Wachsman, W.; Golde, D.W.; Temple, P.A.; Orr, E.C.; Clark, S.C.; Chen, I.S. 1985: HTLV x-gene product: requirement for the env methionine initiation codon. Science 228(4707): 1534-1537
Jonderko, K. 1985: HTLV--human T-cell leukemia virus. Nowotwory 35(2): 127-135
Inoue, J.; Itoh, M.; Akizawa, T.; Toyoshima, H.; Yoshida, M. 1991: HTLV-1 Rex protein accumulates unspliced RNA in the nucleus as well as in cytoplasm. Oncogene 6(10): 1753-1757
Zanke, B.W.; Rush, D.N.; Jeffery, J.R.; Israels, L.G. 1989: HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient. Transplantation 48(4): 695-697
Fujii, M.; Tsuchiya, H.; Seiki, M. 1991: HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity. Oncogene 6(12): 2349-2352
Fujii, M.; Niki, T.; Mori, T.; Matsuda, T.; Matsui, M.; Nomura, N.; Seiki, M. 1991: HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene 6(6): 1023-1029
Bove, J.R.; Sandler, S.G. 1988: HTLV-1 and blood transfusion. Transfusion 28(2): 93-94
Cruickshank, J.K.; Corbin, D.O.; Bucher, B.; Vernant, J.C. 1992: HTLV-1 and neurological disease. Bailliere's Clinical Neurology 1(1): 61-81
Morgan, O.S.; Rodgers-Johnson, P.; Mora, C.; Char, G. 1989: HTLV-1 and polymyositis in Jamaica. Lancet 2(8673): 1184-1187
Montgomery, R.D. 1989: HTLV-1 and tropical spastic paraparesis. 1. Clinical features, pathology and epidemiology. Transactions of the Royal Society of Tropical Medicine and Hygiene 83(6): 724-728
Weber, J. 1989: HTLV-1 and tropical spastic paraparesis. 2. the human T-cell lymphotropic virus type 1. Transactions of the Royal Society of Tropical Medicine and Hygiene 83(6): 729-731
Méry, J.P.; Fessi, H.; Dosquet, P.; Dazza, M.C.; Simon, F.; Elias, A. 1992: HTLV-1 antibodies in hemodialysis patients. Nephron 61(1): 124
Spina-França, A.; Livramento, J.A.; Machado, L.R.; Gomes, H.R.; Vianna, L.S.; Castro, L.H.; Nóbrega, J.P.; Bacheschi, L.A. 1990: HTLV-1 antibodies in serum and cerebrospinal fluid in tropical spastic paraparesis in Brazil. Arquivos de Neuro-Psiquiatria 48(4): 441-447
Wang, T.L.; Liu, T.C.; Chan, L.; Kueh, Y.K.; Wong, S.Y. 1991: HTLV-1 associated T cell lymphoma in South East Asia: case report and family study. Journal of Clinical Pathology 44(8): 692-693
Tonkin, K.S.; Rustin, G.J.; Paradinas, F.J. 1990: HTLV-1 associated T-cell lymphoma in a patient with a 10-year history of non-epidermotropic T-cell skin infiltrates. Clinical Oncology 2(6): 354-357
Fukazawa, T.; Hamada, T.; Hamada, K.; Yanagihara, T.; Tashiro, K.; Morikawa, F. 1991: HTLV-1 associated myelopathy combined with chronic thyroiditis. Journal of Internal Medicine 230(1): 89-90
Power, C.; Weinshenker, B.G.; Dekaban, G.A.; Ebers, G.C.; Francis, G.S.; Rice, G.P. 1989: HTLV-1 associated myelopathy in Canada. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 16(3): 330-335
Cartier, L.; Araya, F.; Castillo, J.L.; Verdugo, R. 1990: HTLV-1 associated myelopathy in Chile. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 17(1): 95
Nakamura, F.; Kajihara, H.; Nakamura, M.; Sasaki, H.; Kumamoto, T.; Okada, K. 1989: HTLV-1 associated myelopathy in an HTLV-1 and HBV double carrier family: report of a case and the mode of vertical transmission of both viruses. Journal of Gastroenterology and Hepatology 4(4): 387-390
Kawano, F.; Tsukamoto, A.; Satoh, M.; Sanada, I.; Shido, T.; Suzushima, H.; Asou, N.; Takatsuki, K. 1992: HTLV-1 associated myelopathy/tropical spastic paraparesis with adult T-cell leukemia. Leukemia 6(1): 66-67
Anonymous 1988: HTLV-1 comes of age. Lancet 1(8579): 217-219
Schulz, T.F.; Calabrò, M.L.; Hoad, J.G.; Carrington, C.V.; Matutes, E.; Catovsky, D.; Weiss, R.A. 1991: HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. Virology 184(2): 483-491
Hemachudha, T.; Niruthisard, S.; Sirivichayakul, S.; Chomchey, P.; Wilde, H. 1992: HTLV-1 has reached Thailand via a heterosexual route. Transactions of the Royal Society of Tropical Medicine and Hygiene 86(4): 434
Lemaire, J.M.; Coste, J.; Courouce, A.M. 1988: HTLV-1 in France. Presse Medicale 17(30): 1542
Schüpbach, J.; Baumgartner, A.; Tomasik, Z. 1988: HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors. International Journal of Cancer 42(6): 857-862
Inostroza, J.; Díaz, P.; Saunier, C. 1990: HTLV-1 in a Mapuche population. Revista Medica de Chile 118(12): 1326-1329
Pujol de la Llave, E.; García Sainz, A.; Ollero Baturone, M.; Nájera Morrondo, R. 1989: HTLV-1 in drug addicts in Andalucia. Medicina Clinica 93(12): 476
Ichimaru, M.; Kamihira, S.; Ikeda, S. 1988: HTLV-1 infection due to mother milk and blood transfusion. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 62 Suppl: 230-239
Soriano, V.; Tor, J.; Ribera, A.; Clotet, B.; Muga, R.; Foz, M. 1989: HTLV-1 infection in Barcelona. Presse Medicale 18(30): 1484
Lee, H.; Anderson, E.; Allain, J.P.; Gonzaga, A. 1989: HTLV-1 infection in Brazil. Blood 73(6): 1742
Weber, J.N.; Banatvala, N.; Clayden, S.; McAdam, K.P.; Palmer, S.; Moulsdale, H.; Tosswill, J.; Dilger, P.; Thorpe, R.; Amann, S. 1989: HTLV-1 infection in Papua new Guinea: evidence for serologic false positivity. Journal of Infectious Diseases 159(6): 1025-1028
Pujol de la Llave, E.; Ollero Baturone, M.; Márquez Ronchel, P.; Gimeno Belmonte, A. 1990: HTLV-1 infection in a population with high risk behavior. Medicina Clinica 94(12): 477
Chandy, M.; Babu, P.G.; Saraswathy, N.K.; Ishida, T.; John, T.J. 1991: HTLV-1 infection in patients with leukaemia in southern India. Lancet 338(8763): 380-381
Planes, N.; Pirola, D.; Sen, L.; Miani Abreu, S.; Peñalver, J.; Estévez, M.E. 1992: HTLV-1 infection in polytransfused patients. Medicina 52(2): 185-187
Dalgleish, A.; Richardson, J.; Matutes, E.; Cruickshank, K.; Newell, A.; Sinclair, A.; Thorpe, R.; Brasher, M.; Weber, J.; Catovsky, D. 1988: HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. Aids Research and Human Retroviruses 4(6): 475-485
Coleman, R.J.; Zuckerman, M.; Swash, M. 1991: HTLV-1 infection: the clinical spectrum widens. Journal of Neurology Neurosurgery and Psychiatry 54(4): 371
Ajdukiewicz, A.; Yanagihara, R.; Garruto, R.M.; Gajdusek, D.C.; Alexander, S.S. 1989: HTLV-1 myeloneuropathy in the Solomon Islands. New England Journal of Medicine 321(9): 615-616
Kanamori, H.; Suzuki, N.; Siomi, H.; Nosaka, T.; Sato, A.; Sabe, H.; Hatanaka, M.; Honjo, T. 1990: HTLV-1 p27rex stabilizes human interleukin-2 receptor alpha chain mRNA. EMBO Journal 9(12): 4161-4166
Dresher, B.E.; Kaye, J.D. 1990: A computational learning model for metrical phonology. Cognition 34(2): 137-195
Itoh, M.; Inoue, J.; Toyoshima, H.; Akizawa, T.; Higashi, M.; Yoshida, M. 1989: HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve suppression of unspliced RNA expression. Oncogene 4(11): 1275-1279
Nakamura, J.; Kawahara, K.; Kwock, D.; Kimata, J.; Kaneshiro, S.; Nakamura, S.; Yanagihara, E. 1988: HTLV-1 seroconversion in a 56-year-old Japanese woman undergoing chemotherapy for acute nonlymphocytic leukemia. Hawaii Medical Journal 47(6): 269-270; 273
Manca, N.; Caruso, A.; Bonfanti, C.; Savoldi, E.; Li Vigni, R.; Pirali, F.; Sapelli, P.L.; Turano, A. 1989: HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy. European Journal of Epidemiology 5(1): 37-41
Brindle, R.J.; Eglin, R.P.; Parsons, A.J.; Hill, A.V.; Selkon, J.B. 1988: HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey. Epidemiology and Infection 100(1): 153-156
Lugaresi, A.; Uncini, A.; Porrini, A.M.; Battista, P.; French, D.; Curia, M.C.; Mammarella, S.; Mariani-Costantini, R.; Gambi, D. 1991: HTLV-1-associated myeloneuropathy in an Italian. Acta Neurologica Scandinavica 84(3): 186-191
Kishimoto, M.; Araga, S.; Adachi, Y.; Takahashi, K. 1990: HTLV-1-associated myelopathy (HAM) with OKT4 epitope deficiency. Acta Neurologica Scandinavica 81(5): 475
Wang, S.J.; Liu, H.C.; Chi, C.W.; Liu, T.Y.; Chen, P.M. 1991: HTLV-1-associated myelopathy: first case reported in Taiwan. Acta Neurologica Scandinavica 84(3): 256-258
Sterry, W.; Siebel, A.; Mielke, V. 1992: HTLV-1-negative pleomorphic T-cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients. British Journal of Dermatology 126(5): 456-462
Fisher, E.J. 1986: HTLV-3 produces a broad range of illness. Michigan Medicine 85(3): 96-98
Blumberg, B.S.; Blanton, S.H.; Shrager, D.I.; Blattner, W.A. 1989: HTLV-i (Philadelphia, 1969). Lancet 2(8658): 327-328
Iannone, R.; Sherman, M.P.; Rodgers-Johnson, P.E.; Beilke, M.A.; Mora, C.A.; Amin, R.M.; Tinsley, S.R.; Papsidero, L.D.; Poiesz, B.J.; Gibbs, C.J. 1992: HTLV-i DNA sequences in CNS tissue of a patient with tropical spastic paraparesis and HTLV-I-associated myelopathy. Journal of Acquired Immune Deficiency Syndromes 5(8): 810-816
Semmes, O.J.; Jeang, K.T. 1992: HTLV-I Tax is a zinc-binding protein: role of zinc in Tax structure and function. Virology 188(2): 754-764
Sandler, S.G. 1986: HTLV-i and -II. new risks for recipients of blood transfusions?. JAMA 256(16): 2245-2246
Gradilone, A.; Zani, M.; Barillari, G.; Modesti, M.; Agliano, A.M.; Maiorano, G.; Ortona, L.; Frati, L.; Manzari, V. 1986: HTLV-i and HIV infection in drug addicts in Italy. Lancet 2(8509): 753-754
Manzari, V.; Modesti, M.; De Marchis, L.; Gradilone, A.; Cifaldi, L.; Marchei, P. 1990: HTLV-I and HIV-1 infection in patients with lymphadenopathy syndrome detected during routine breast screening at a tumor prevention center. Aids Research and Human Retroviruses 6(3): 417-421
Dowell, S.F.; Halsey, N.A.; Boulos, R.; Brutus, J.R.; Holt, E.; Quinn, T.C.; Blattner, W.; McArthur, J.; Gershman, K.; Ruff, A. 1989: HTLV-i and HIV-1-associated neurologic abnormalities; syphilis as a confounding factor. Aids 3(11): 763-764
Gulisano, G.; Ciccia, M.; Ienna, M.; Cipolla, A.; Mauro, L. 1991: HTLV-i and HIV-i antibody frequency in thalassemics and drug addicts in southeast Sicily. Bollettino Dell'istituto Sieroterapico Milanese 70(1-2): 531-534
Muchinik, G.; Bouzas, M.B.; Zapiola, I.; Decaro, J.; García, L.; Gallo, D.; Hanson, C.V. 1992: HTLV-i and HTLV-Ii infection in Uruguay. Journal of Acquired Immune Deficiency Syndromes 5(7): 743-744
Rodgers-Johnson, P.; Gajdusek, D.C.; Morgan, O.S.; Zaninovic, V.; Sarin, P.S.; Graham, D.S. 1985: HTLV-i and HTLV-IIi antibodies and tropical spastic paraparesis. Lancet 2(8466): 1247-1248
Senba, M.; Nakamura, T.; Kawai, K.; Senba, M.I. 1991: HTLV-i and acute pancreatitis. Lancet 337(8755): 1489
Bolton, W.V.; Wylie, B.R.; Kenrick, K.G.; Archer, G.T.; Hyland, C.A.; Parker, S.L.; Young, I.F.; Maloney, R.K.; Armstrong, V.A.; Keller, A.J. 1989: HTLV-i and blood donors. Lancet 1(8650): 1324-1325
Koprowski, H.; DeFreitas, E. 1988: HTLV-i and chronic nervous diseases: present status and a look into the future. Annals of Neurology 23 Suppl: S166-S170
Handzel, Z.T. 1988: HTLV-i and human disease. Israel Journal of Medical Sciences 24(8): 395-396
Prin, L.; Leguern, M.; Ameisen, J.C.; Saragosti, S.; Bletry, O.; Fenaux, P.; Levy, J.P.; Capron, A. 1988: HTLV-i and malignant hypereosinophilic syndrome. Lancet 2(8610): 569-570
Psakhis, M.B.; Pekker, I.S. 1989: Metrologic aspects of interactions of probing currents with the impedance of biological objects in the system of temporary channel separation in rheographic equipment. Meditsinskaia Tekhnika 9(1): 37-40
Richardson, J.H.; Newell, A.L.; Newman, P.K.; Mani, K.S.; Rangan, G.; Dalgleish, A.G. 1989: HTLV-i and neurological disease in South India. Lancet 1(8646): 1079
Bartholomew, C.; Cleghorn, F.; Charles, W.; Ratan, P.; Roberts, L.; Maharaj, K.; Jankey, N.; Daisley, H.; Hanchard, B.; Blattner, W. 1986: HTLV-i and tropical spastic paraparesis. Lancet 2(8498): 99-100
Gessain, A.; Francis, H.; Sonan, T.; Giordano, C.; Akani, F.; Piquemal, M.; Caudie, C.; Malone, G.; Essex, M.; de-Thé, G. 1986: HTLV-i and tropical spastic paraparesis in Africa. Lancet 2(8508): 698
Mochizuki, M.; Yamaguchi, K.; Takatsuki, K.; Watanabe, T.; Mori, S.; Tajima, K. 1992: HTLV-i and uveitis. Lancet 339(8801): 1110
Pandolfi, F.; Shriver, K.; Scarselli, E.; Fiorelli, V.; Semenzato, G.; Zambello, R.; Chisesi, T.; de Rossi, G.; Strong, D.M. 1987: HTLV-i antibodies and lymphoproliferative disease of granular lymphocytes. Lancet 2(8574): 1527
Lange Wantzin, G.; Saxinger, C.; Thomsen, K. 1985: HTLV-i antibodies associated with cutaneous T cell lymphoma in Denmark. Haematology and Blood Transfusion 29: 335-337
Currie, B.; Hinuma, Y.; Imai, J.; Cumming, S.; Doherty, R. 1989: HTLV-i antibodies in Papua new Guinea. Lancet 1(8647): 1137
Williams, D.L.; Ragab, A.H.; McDougal, J.S. 1985: HTLV-i antibodies in childhood leukemia. JAMA 253(17): 2496
Sanhadji, K.; Gessain, A.; Chout, R.; Sasco, A.J.; Yoyo, M.; Touraine, J.L.; de Thé, G. 1987: HTLV-i antibody and cell-mediated immunity status in sickle cell anemia. Clinical Immunology and Immunopathology 43(1): 140-144
Schwarzfischer, G.; Schätzl, H.; Bäcker, U.; Weise, W.; von der Helm, K.; Deinhardt, F. 1991: HTLV-i antibody screening of blood donors. Beitrage Zur Infusionstherapie 28: 29-31
Chorba, T.L.; Jason, J.M.; Ramsey, R.B.; Lechner, K.; Pabinger-Fasching, I.; Kalyanaraman, V.S.; McDougal, J.S.; Cabradilla, C.D.; Tregillus, L.C.; Lawrence, D.N. 1985: HTLV-i antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS. Thrombosis and Haemostasis 53(2): 180-182
Sanders, R.C.; Levin, A.; Anian, G.; Webber, I.; Lee, H.; Swanson, P.; Diwan, A.; Desowitz, R.; Blattner, W.A.; Alpers, M.P. 1990: HTLV-i antibody studies in villagers in East Sepik Province, Papua new Guinea. Archives of Virology 114(1-2): 27-35
Yap, S.F.; Peh, S.C.; Chan, L.; Wong, H.C.; How, V.J.; Looi, L.M. 1992: HTLV-I antibody study in normal individuals and unselected hospital patients in Malaysia. Southeast Asian Journal of Tropical Medicine and Public Health 23(1): 26-29
Kamihira, S.; Moriuchi, Y.; Tagawa, M.; Matsuo, K. 1986: HTLV-i associated T-cell lymphoma terminating in B-cell lymphoma. Japanese Journal of Clinical Hematology 27(2): 238-241
Eguchi, K.; Nakamura, T.; Mine, M.; Ida, H.; Kawakami, A.; Migita, K.; Nagasato, K.; Kurata, A.; Fukuda, T.; Nagataki, S. 1992: HTLV-i associated arthritis: characteristics of an HTLV-i virus infected T cell line from synovial fluid. Annals of the Rheumatic Diseases 51(5): 673-677
Kitajima, I.; Sato, K.; Nishioka, K.; Yamamoto, K. 1990: HTLV-I associated arthropathy (HAAP). Nihon Rinsho. Japanese Journal of Clinical Medicine 48(4): 854-860
Sahashi, K.; Ibi, T.; Tuchiya, I.; Morishima, T.; Takahashi, A. 1989: HTLV-I associated encephalo-myelopathy resembling ALS with concurrence of acute promyelocytic leukemia in a member of the relatives. Rinsho Shinkeigaku 29(1): 98-101
Tashiro, T.; Ono, T.; Nagai, H.; Yamasaki, H.; Kuroda, Y.; Shigeno, H.; Goto, J.; Kikuchi, H.; Nasu, M. 1990: HTLV-I associated interstitial pneumonia--a case report and bronchoalveolar lavage study. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 64(4): 492-497
Ge, T.; Wang, G.; Zhao, B. 1992: HTLV-i associated myelopathy. Zhonghua Shen Jing Jing Shen Ke Za Zhi 25(3): 182-184
Kurosawa, M.; Machii, T.; Kitani, T.; Tokumine, Y.; Kawa, K.; Maekawa, I.; Kawamura, T.; Miyake, T.; Kanda, M. 1991: HTLV-i associated myelopathy (HAM) after blood transfusion in a patient with CD2+ hairy cell leukemia. American Journal of Clinical Pathology 95(1): 72-76
Suoh, H.; Sahashi, K.; Ibi, T.; Tashiro, M.; Mitsuma, T. 1991: HTLV-i associated myelopathy (HAM) and sarcoid myopathy. Rinsho Shinkeigaku 31(7): 746-749
Tanaka, T.; Takagi, A.; Kojima, S.; Goto, J.; Tanaka, M. 1989: HTLV-i associated myelopathy (HAM) complicated with chronic polymyositis. Rinsho Shinkeigaku 29(1): 102-107
Mita, M.; Konno, I.; Kawaguchi, M.; Kanbayashi, H.; Abe, R.; Matsuda, S.; Uchida, T.; Kariyone, S. 1987: HTLV-i associated myelopathy (HAM) in Fukushima Prefecture. Japanese Journal of Clinical Hematology 28(9): 1657-1662
Kawai, H.; Nishida, Y.; Takagi, M.; Nakamura, S.; Saito, S. 1989: HTLV-i associated myelopathy (HAM) with adult T-cell leukemia (ATL). Rinsho Shinkeigaku 29(5): 588-592
Castro, L.H.; Chaves, C.J.; Callegaro, D.; Nóbrega, J.P.; Scaff, M. 1989: HTLV-I associated myelopathy in Brazil: a preliminary report. Arquivos de Neuro-Psiquiatria 47(4): 501-502
Meireles, A.; Moreira Júnior, E.D.; Moreno-Carvalho, O.A.; Badaro, R.; Melo, A. 1992: HTLV-i associated myelopathy in Salvador (northeastern Brazil). Arquivos de Neuro-Psiquiatria 50(2): 189-190
Motomura, M.; Nakamura, T.; Nagasato, K.; Shibayama, K.; Kubo, S.; Nakasono, I.; Tsujihata, M.; Sonoda, S.; Yashiki, S. 1990: HTLV-i associated myelopathy in an identical twin. Lancet 336(8706): 55
Kawai, H.; Kashiwagi, S.; Sano, Y.; Inui, T.; Saito, S. 1991: HTLV-I associated myelopathy with Hashimoto's thyroiditis--a report of two cases. Rinsho Shinkeigaku 31(6): 648-652
Noda, K.; Isozaki, E.; Miyamoto, K.; Nagashima, T.; Tanabe, H. 1992: HTLV-I associated myelopathy with bilateral abductor vocal cord paralysis--case report. Rinsho Shinkeigaku 32(3): 324-326
Hara, Y.; Takahashi, M.; Yoshikawa, H.; Yorifuji, S.; Tarui, S. 1988: HTLV-i associated myelopathy with multiple spotty areas found in the cerebral white matter and brain stem by MRi. Rinsho Shinkeigaku 28(1): 92-96
Osame, M.; Usuku, K.; Izumo, S.; Ijichi, N.; Amitani, H.; Igata, A.; Matsumoto, M.; Tara, M. 1986: HTLV-i associated myelopathy, a new clinical entity. Lancet 1(8488): 1031-1032
Hino, S.; Doi, H.; Yoshikuni, H.; Sugiyama, H.; Ishimaru, T.; Yamabe, T.; Tsuji, Y.; Miyamoto, T. 1987: HTLV-i carrier mothers with high-titer antibody are at high risk as a source of infection. Japanese Journal of Cancer Research: Gann 78(11): 1156-1158
Tajima, K.; Tominaga, S.; Suchi, T.; Fukui, H.; Komoda, H.; Hinuma, Y. 1986: HTLV-I carriers among migrants from an ATL-endemic area to ATL non-endemic metropolitan areas in Japan. International Journal of Cancer 37(3): 383-387
Cartier, L.; Araya, F.; Castillo, J.L. 1992: HTLV-i clinical pathological spectrum. Revista Medica de Chile 120(8): 927-933
Phillips, I.; Hyams, K.C.; Wignall, F.S.; Moran, A.Y.; Gotuzzo, E.; Sanchez, J.; Roberts, C.R. 1991: HTLV-I coninfection in a HIV-1-infected Peruvian population. Journal of Acquired Immune Deficiency Syndromes 4(3): 301-302
Cousergue, C. 1988: HTLV-i demonstrated in chronic progressive myelopathy. Presse Medicale 17(34): 1724
Bouzas, M.B.; Picchio, G.; Muchinik, G.; Campestri, R.; Cahn, P.; Perez, H.; Gallo, D.; Hanson, C.V. 1990: HTLV-I in Argentina. Journal of Acquired Immune Deficiency Syndromes 3(7): 741-742
Tosswill, J.H.; Parry, J.V. 1989: HTLV-i in English patients. Lancet 2(8658): 328
Spiegel, A.; Cartel, J.L.; Chungue, E.; Philippon, G.; Martin, P.M.; Cardines, R.; Laudon, F. 1991: HTLV-i in French Polynesia: a serological survey in sexually exposed groups. Medical Journal of Australia 155(10): 718
Soriano, V.; Tor, J.; Monzon, M.; Graus, J.M.; Clotet, B.; Ribas-Mundo, M. 1990: HTLV-i in Spain. Lancet 336(8715): 627-628
Macchi, B. 1992: HTLV-i in neurological diseases. Italian Journal of Neurological Sciences 13(9 Suppl 14: 31-36
Soriano, V.; Tor, J.; Ribera, J.M.; Flores, A.; Casals, A.; Ribas-Mundó, M. 1990: HTLV-i in patients from Barcelona with connective tissue diseases, neurologic demyelinating diseases and lymphoproliferative syndromes. Medicina Clinica 94(19): 730-732
Shimamoto, Y.; Yamaguchi, M. 1992: HTLV-i induced extranodal lymphomas. Leukemia and Lymphoma 7(1-2): 37-45
Habibi, B. 1987: HTLV-i infection and blood transfusion. Revue Francaise de Transfusion et Immuno-Hematologie 30(1): 39-55
Mann, D.L.; LeSane, F.; Boumpas, D.; Dean, M.; Blattner, W.A. 1988: HTLV-i infection and chronic lymphocytic leukemia. Nouvelle Revue Francaise d'Hematologie 30(5-6): 267-273
Araujo, A.d.Q.; Ali, A.; Newell, A.; Dalgleish, A.G.; Rudge, P. 1992: HTLV-i infection and neurological disease in Rio de Janeiro. Journal of Neurology Neurosurgery and Psychiatry 55(2): 153-155
Mattock, C.; Parker, N.E. 1985: HTLV-i infection and schizophrenia. Lancet 2(8461): 945
Siwek, J. 1989: HTLV-i infection and the family physician. American Family Physician 40(2): 91-92
Anonymous 1990: HTLV-I infection in Britain. Bmj 301(6749): 442-443
Nightingale, S.; Desselberger, U. 1990: HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. Bmj 300(6725): 679
Frery, N.; Chavance, M.; Valette, I.; Schaffar, L.; Neisson-Vernant, C.; Jouannelle, J.; Monplaisir, N. 1991: HTLV-i infection in French West Indies: a case-control study. European Journal of Epidemiology 7(2): 175-182
Denic, S.; Nolan, P.; Doherty, J.; Garson, J.; Tuke, P.; Tedder, R. 1990: HTLV-i infection in Iraq. Lancet 336(8723): 1135-1136
Pujol, E.; Ollero, M.; Gimeno, A.; Colchero, J.; Alcoucer, R.; Márquez, P. 1990: HTLV-i infection in a high-risk group. Anales de Medicina Interna 7(7): 349-352
Esparza, B.; Santamaría, J.M.; Miguel, F.; Saenz de Ugarte, J.R.; Aizpiri, J.; Merino, F. 1991: HTLV-i infection in high-risk groups in Vizcaya, northern Spain. Aids Research and Human Retroviruses 7(7): 569-570
Spalton, D.J.; Nicholson, F. 1991: HTLV-i infection in human disease. British Journal of Ophthalmology 75(3): 174-175
Politis, C.; Papaevangelou, G.; Sinakos, Z.; Trichopoulou, E.; Roumeliotou, A. 1989: HTLV-i infection in multitransfused patients with thalassemia. Transfusion 29(6): 561
Pujol, E.; Ollero, M.; Márquez, P.; Gea, A.; Alcoucer, R.; Gimeno, A. 1991: HTLV-i infection in sailors who travel to sub-Saharan West Africa. Enfermedades Infecciosas y Microbiologia Clinica 9(5): 283-285
De Stasio, G.; Lattanzio, A.; Rizzi, L.; Lancieri, M.; Canavaggio, M.; Shreiber, L.; Lee, H. 1989: HTLV-i infection is not endemic in Apulia (southern Italy). International Journal of Cancer 44(6): 1132-1133
Franchini, G.; Mann, D.L.; Popovic, M.; Zicht, R.R.; Gallo, R.C.; Wong-Staal, F. 1985: HTLV-i infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-i from B cells to normal T cells. Leukemia Research 9(11): 1305-1314
DeFreitas, E.; Wroblewska, Z.; Maul, G.; Sheremata, W.; Ferrante, P.; Lavi, E.; Harper, M.; di Marzo-Veronese, F.; Koprowski, H. 1987: HTLV-i infection of cerebrospinal fluid T cells from patients with chronic neurologic disease. Aids Research and Human Retroviruses 3(1): 19-32
Ellenberg, S.S. 1989: Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials. Oncology 3(8): 39-46; Discussion 48, 51
Wolter, M.; Schleussner-Samuel, P.; Marsch, W.C. 1991: HTLV-i infection: ungual T-cell lymphoma as a primary manifestation. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 42(1): 50-52
Moynet, D.; Berteau, F.; Astier-Gin, T.; Legrand, E.; Sainte-Foie, S.; Joly, F.; Moreau, J.P.; Guillemain, B. 1992: HTLV-i infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques. Leukemia 6(Suppl 3): 106s-109s
Manzari, V.; Gradilone, A.; Barillari, G.; Zani, M.; Collalti, E.; Pandolfi, F.; De Rossi, G.; Liso, V.; Babbo, P.; Robert-Guroff, M. 1985: HTLV-i is endemic in southern Italy: detection of the first infectious cluster in a white population. International Journal of Cancer 36(5): 557-559
Saida, T.; Saida, K.; Funauchi, M.; Nishiguchi, E.; Nakajima, M.; Matsuda, S.; Ohta, M.; Ohta, K.; Nishitani, H.; Hatanaka, M. 1988: HTLV-i myelitis: isolation of virus, genomic analysis, and infection in neural cell cultures. Annals of the new York Academy of Sciences 540: 636-638
Sowa, J.M. 1992: HTLV-i myelopathy. Neurology 42(11): 2232-2233
Ishikawa, T.; Yabe, H.; Nagai, K.; Nakayama, S.; Hattori, T.; Takatsuki, K.; Uchiyama, T.; Uchino, H.; Ito, T. 1988: HTLV-I negative T helper/inducer phenotype chronic lymphocytic leukemia associated with OKT3 epitope deficiency--a case report. Japanese Journal of Clinical Hematology 29(9): 1417-1421
Macchi, B.; Caronti, B.; Gremo, F.; Torelli, S.; Bonmassar, E.; Lauro, G.M. 1991: HTLV-i neurotropism. in vitro studies. Acta Neurologica 13(2): 179-183
Segal-Eiras, A.; Croce, M.V. 1991: HTLV-i p24 antigen in circulating immune complexes associated with acute T-lymphoblastic leukemia. Haematologica 76(5): 441-442
Dokhelar, M.C.; Pickford, H.; Sodroski, J.; Haseltine, W.A. 1989: HTLV-i p27rex regulates gag and env protein expression. Journal of Acquired Immune Deficiency Syndromes 2(5): 431-440
Wiley, C.A.; Nerenberg, M.; Cros, D.; Soto-Aguilar, M.C. 1989: HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. New England Journal of Medicine 320(15): 992-995
Fanin, R.; Minutillo, S.; D'Agaro, P.; Raspadori, D.; Tassinari, A.; Tazzari, P.; Testoni, N.; Damiani, D.; Gallizia, C.; Michieli, M. 1990: HTLV-I positive adult T-cell leukaemia-lymphoma: report of a typical case from Italy. Haematologica 75(4): 375-380
Gessain, A.; Boeri, E.; Kazadi, K.; Garin, B.; Salaün, J.J.; Gallo, R.; de Thé, G.; Franchini, G. 1992: HTLV-i retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene. Comptes Rendus de l'Academie des Sciences. Serie Iii Sciences de la Vie 314(4): 159-164
Cartier, L.; Araya, F.; Castillo, J.L.; Verdugo, R.; Mora, C.; Gajdusek, D.C.; Gibbs, C.J. 1990: HTLV-i retrovirus in Chile: study on 140 neurological patients. Revista Medica de Chile 118(6): 622-628
Oksenberg, J.R.; Mantegazza, R.; Sakai, K.; Bernard, C.C.; Steinman, L. 1990: HTLV-i sequences are not detected in peripheral blood genomic DNA or in brain cDNA of multiple sclerosis patients. Annals of Neurology 28(4): 574-577
Sánchez, G.; Vásquez, P. 1991: HTLV-i seroprevalence in blood donors. Revista Medica de Chile 119(5): 600
Asou, N.; Kumagai, T.; Uekihara, S.; Ishii, M.; Sato, M.; Sakai, K.; Nishimura, H.; Yamaguchi, K.; Takatsuki, K. 1986: HTLV-i seroprevalence in patients with malignancy. Cancer 58(4): 903-907
Ballard, D.W.; Böhnlein, E.; Lowenthal, J.W.; Wano, Y.; Franza, B.R.; Greene, W.C. 1988: HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 241(4873): 1652-1655
Shinohara, T. 1991: HTLV-I tax mediated activation of cellular genes in transgenic mice. Hokkaido Journal of Medical Science 66(4): 534-543
Jeang, K.T.; Widen, S.G.; Semmes, O.J.; Wilson, S.H. 1990: HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 247(4946): 1082-1084
Fretz, C.; Jaulmes, D.; Jordan, G.; Fournel, J.J.; Jullien, A.M.; Gout, O.; Gluckman, J.C.; De The, G. 1991: HTLV-I transmission and myelopathy induced by blood transfusion. Transfusion 31(4): 379
Inaba, S. 1991: HTLV-i transmission by blood transfusion. Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 88: 171-175
Mochizuki, M.; Watanabe, T.; Yamaguchi, K.; Takatsuki, K.; Yoshimura, K.; Shirao, M.; Nakashima, S.; Mori, S.; Araki, S.; Miyata, N. 1992: HTLV-i uveitis: a distinct clinical entity caused by HTLV-i. Japanese Journal of Cancer Research: Gann 83(3): 236-239
Delamarter, R.B.; Carr, J.; Saxton, E.H. 1990: HTLV-i viral-associated myelopathy after blood transfusion in a multiple trauma patient. Clinical Orthopaedics and Related Research 260: 191-194
Gessain, A.; Saal, F.; Gout, O.; De-Thé, G.; Périès, J. 1988: HTLV-i virus and associated chronic neuromyelopathies. Current data and hypotheses. Nouvelle Revue Francaise d'Hematologie 30(1-2): 15-20
Mayer, V.; Ebbesen, P. 1991: HTLV-i virus in Europeans: the continuous spread. a meta-analysis. Acta Virologica 35(5): 472-495
Agius, G.; Vaillant, V.; Dindinaud, G.; Bazillou, M.; Zagury, J.F.; Kolesnitchenko, V.; Castets, M. 1989: HTLV-I, HIV-1 and HIV-2 seroprevalences in Guadeloupe, French West Indies. European Journal of Epidemiology 5(4): 532-533
Sarin, P.S. 1988: HTLV-I, adult T-cell leukemia, and tropical spastic paraparesis. Annals of Neurology 23 Suppl: S181-S184
Tournier-Lasserve, E.; Gout, O.; Gessain, A.; Iba-Zizen, M.T.; Lyon-Caen, O.; Lhermitte, F.; de-Thé, G. 1987: HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis. Lancet 2(8549): 49-50
Blattner, W.A.; Saxinger, C.W.; Gallo, R.C. 1985: HTLV-I, the prototype human retrovirus: epidemiologic features. Progress in Clinical and Biological Research 182: 223-243
Montgomery, R.D. 1986: HTLV-I, visna, and tropical spastic paraparesis. Lancet 2(8500): 227-228
Blomberg, J. 1989: HTLV-I--a prototype in a growing group of leukemogenic viruses. Lakartidningen 86(24): 2294-2296
Anonymous 1990: HTLV-I--a screen too many?. Lancet 336(8724): 1161
Mann, D.L.; DeSantis, P.; Mark, G.; Pfeifer, A.; Newman, M.; Gibbs, N.; Popovic, M.; Sarngadharan, M.G.; Gallo, R.C.; Clark, J. 1987: HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science 236(4805): 1103-1106
Yim, M.; Hayashi, T.; Yanagihara, E.; Kadin, M.; Nakamura, J. 1986: HTLV-I-associated T-cell leukemia in Hawaii. American Journal of the Medical Sciences 292(5): 325-327
Leor, J.; Langevitz, P.; Trau, H.; Schinder, E.O.; Douer, D.; Ben-Bassat, I. 1988: HTLV-I-associated T-cell leukemia/lymphoma in Israel. Israel Journal of Medical Sciences 24(8): 397-400
Yancey, W.B.; Dolson, L.H.; Oblon, D.; Smith, L.J.; Braylan, R.; Longley, S.; Williams, R.C. 1990: HTLV-I-associated adult T-cell leukemia/lymphoma presenting with nodular synovial masses. American Journal of Medicine 89(5): 676-683
Bunn, P.A. 1989: HTLV-I-associated diseases. Western Journal of Medicine 150(5): 578-579
Stepina, V.N.; Seniuta, N.B.; Pavlish, O.A.; Iakovleva, L.S.; Pivnik, A.V.; Al-Radi, L.S.; Osmanov, E.A.; Gurova, E.P.; Miasnikova, I.N.; Kologrivova, Z.A. 1991: HTLV-I-associated hemoblastoses in different regions of the USSR. Voprosy Virusologii 36(2): 159-162
Murphy, E.L.; Blattner, W.A. 1988: HTLV-I-associated leukemia: a model for chronic retroviral diseases. Annals of Neurology 23 Suppl: S174-S180
Cappell, M.S.; Chow, J. 1987: HTLV-I-associated lymphoma involving the entire alimentary tract and presenting with an acquired immune deficiency. American Journal of Medicine 82(Special Issue 3): 649-654
Yokota, T.; Yamada, M.; Furukawa, T.; Tsukagoshi, H. 1988: HTLV-I-associated meningitis. Journal of Neurology 235(3): 129-130
Osame, M. 1992: HTLV-I-associated myelopathy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 81(3): 389-392
Osame, M. 1990: HTLV-I-associated myelopathy (HAM). Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 35(7 Suppl): 1320-1326
Kawai, H.; Nishida, Y.; Sano, Y.; Takagi, M.; Mizobuchi, M.; Miyake, M.; Kashiwagi, S.; Naruo, T.; Inui, T.; Masuda, K. 1991: HTLV-I-associated myelopathy (HAM) in Tokushima Prefecture--geographical and clinical studies in an area between endemic and non-endemic areas of HTLV-i infection. Japanese Journal of Medicine 30(6): 534-541
Kawai, H.; Kashiwagi, S.; Inui, T.; Tamaki, Y.; Sano, Y.; Saito, S. 1991: HTLV-I-associated myelopathy (HAM/TSP) with Hashimoto's thyroiditis. Tokushima Journal of Experimental Medicine 38(3-4): 99-102
Shoji, H.; Kuwasaki, N.; Natori, H.; Kaji, M.; Miyamoto, Y.; Usuku, K.; Sonoda, S.; Osame, M. 1989: HTLV-I-associated myelopathy and adult T-cell leukemia cases in a family. European Neurology 29(1): 33-35
Kaplan, J.E.; Litchfield, B.; Rouault, C.; Lairmore, M.D.; Luo, C.C.; Williams, L.; Brew, B.J.; Price, R.W.; Janssen, R.; Stoneburner, R. 1991: HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology 41(2): 192-197
McKendall, R.R.; Oas, J.; Lairmore, M.D. 1991: HTLV-I-associated myelopathy endemic in Texas-born residents and isolation of virus from CSF cells. Neurology 41(6): 831-836
Windsor, I.M.; Bill, P.L.; Bhigjee, A.I.; Haribhai, H.C.; Kelbe, C.; Hoffman, M.; Modi, C. 1988: HTLV-I-associated myelopathy in Natal. South African Medical Journal 74(7): 370
Honig, L.S.; Lipka, J.J.; Young, K.Y.; Weiss, J.H.; Foung, S.K. 1991: HTLV-I-associated myelopathy in a Californian: diagnosis by reactivity to a viral recombinant antigen. Neurology 41(3): 448-450
Yasui, C.; Fukaya, T.; Koizumi, H.; Kobayashi, H.; Ohkawara, A. 1991: HTLV-I-associated myelopathy in a patient with adult T-cell leukemia. Journal of the American Academy of Dermatology 24(4): 633-637
Kawai, H.; Nishida, Y.; Takagi, M.; Nakamura, K.; Masuda, K.; Saito, S.; Shirakami, A. 1989: HTLV-I-associated myelopathy with adult T-cell leukemia. Neurology 39(8): 1129-1131
Matsumuro, K.; Osame, M.; Eiraku, N.; Machigashira, K.; Izumo, S.; Otsuka, K.; Otani, S.; Mori, M.; Harada, S.; Yanagi, K. 1990: HTLV-I-associated myelopathy, tropical spastic paraparesis, and Borrelia burgdorferi. Annals of Neurology 27(3): 337
Janssen, R.S.; Kaplan, J.E.; Khabbaz, R.F.; Hammond, R.; Lechtenberg, R.; Lairmore, M.; Chiasson, M.A.; Punsalang, A.; Roberts, B.; McKendall, R.R. 1991: HTLV-I-associated myelopathy/tropical spastic paraparesis in the United States. Neurology 41(9): 1355-1357
Igata, A. 1987: HTLV-I-associated myelopathy: an overview. Princess Takamatsu Symposia 18: 181-186
Bhigjee, A.I.; Wiley, C.A.; Wachsman, W.; Amenomori, T.; Pirie, D.; Bill, P.L.; Windsor, I. 1991: HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord. Neurology 41(12): 1990-1992
Grimaldi, L.M.; Roos, R.P.; Devare, S.G.; Casey, J.M.; Maruo, Y.; Hamada, T.; Tashiro, K. 1988: HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-i p24 antibody. Annals of Neurology 24(6): 727-731
Annunziata, P.; Fanetti, G.; Giarratana, M.; Aucone, A.M.; Guazzi, G.C. 1987: HTLV-I-associated spastic paraparesis in an Italian woman. Lancet 2(8572): 1393-1394
Vernant, J.C.; Maurs, L.; Gout, O.; Buisson, G.; Plumelle, Y.; Neisson-Vernant, C.; Monplaisir, N.; Román, G.C. 1988: HTLV-I-associated tropical spastic paraparesis in Martinique: a reappraisal. Annals of Neurology 23 Suppl: S133-S135
Duggan, D.B.; Ehrlich, G.D.; Davey, F.P.; Kwok, S.; Sninsky, J.; Goldberg, J.; Baltrucki, L.; Poiesz, B.J. 1988: HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-i sequences in tumor DNA. Blood 71(4): 1027-1032
Liberski, P.P.; Rodgers-Johnson, P.; Char, G.; Piccardo, P.; Gibbs, C.J.; Gajdusek, D.C. 1988: HTLV-I-like viral particles in spinal cord cells in Jamaican tropical spastic paraparesis. Annals of Neurology 23 Suppl: S185-S187
Shih, L.Y.; Kuo, T.T.; Dunn, P.; Liaw, S.J. 1992: HTLV-I-positive and HTLV-I-negative peripheral T-cell lymphomas in Taiwan Chinese. International Journal of Cancer 50(2): 186-191
Gurtsevitch, V.; Senjuta, N.; Pavlish, O.; Shih, J.; Stepina, V.; Syrtsev, A.; Potekhin, O.; Lenoir, G.M. 1992: HTLV-I-positive case of ATL in Georgia (formerly USSR). International Journal of Cancer 51(5): 835-836
Botha, M.C.; Jones, M.; de Klerk, W.A.; Yamamoto, N.; Kobayashi, S. 1985: HTLV-I-reactive antibody in the northern and eastern Transvaal. South African Medical Journal 67(18): 707
Saal, J.G.; Schneider, E.M.; Müller, C.; Waller, H.D. 1987: HTLV-I-related agent and non-Hodgkin lymphomas in married couple. Lancet 1(8534): 686-687
Dalgleish, A.G. 1985: HTLV-I/Ii and T-cell proliferation. Lancet 2(8467): 1302
Coste, J.; Lemaire, J.M.; Barin, F.; Courouce, A.M. 1990: HTLV-I/Ii antibodies in French blood donors. Lancet 335(8698): 1167-1168
Salker, R.; Tosswill, J.H.; Barbara, J.A.; Runganga, J.; Contreras, M.; Tedder, R.S.; Parra-Mejia, N.; Mortimer, P.P. 1990: HTLV-I/Ii antibodies in UK blood donors. Lancet 336(8710): 317
de Saussure, P.; Chofflon, M.; Pugin, P.; Bierens de Hahn, D.; Perrin, L. 1991: HTLV-I/II in Switzerland: apropos of 4 case reports. Schweizerische Medizinische Wochenschrift 121(48): 1761-1766
Courtois, F.; Barin, F.; Larsen, M.; Brossard, Y.; Masselin, A.; Engelman, P. 1990: HTLV-I/Ii infection in pregnant women in Paris. Lancet 335(8697): 1103
Safrin, S.; Ng, V.L.; McGrath, M.S.; Dattel, B.J.; Hauer, L.; Sweet, R.L. 1990: HTLV-I/II infection in women with acute pelvic inflammatory disease. JAMA 263(16): 2181
Kaplan, J.E.; Khabbaz, R.F. 1989: HTLV-I: newest addition to blood donor screening. American Family Physician 40(2): 189-195
Cohen, I. 1988: HTLV-I: the forgotten retrovirus. Medical and Pediatric Oncology 16(1): 48-56
Barnes, D.M. 1988: HTLV-I: to test or not to test. Science 242(4877): 372-373
Sehgal, R. 1991: Use of inactivated or oral poliovirus vaccine in India. Lancet 338(8772): 945
Moreira Júnior, E.D.; Harrington Júnior, W.; Ribeiro, T.T.; Melo, A.; Brites, C.; Badaró, R.; Swanson, P.; Lee, H. 1992: HTLV-Ii and a new endemic area for HTLV-i in Brazil. Revista da Sociedade Brasileira de Medicina Tropical 25(2): 141-143
Rosenblatt, J.D.; Chen, I.S.; Golde, D.W. 1988: HTLV-Ii and human lymphoproliferative disorders. Clinics in Laboratory Medicine 8(1): 85-95
Heneine, W.; Kaplan, J.E.; Gracia, F.; Lal, R.; Roberts, B.; Levine, P.H.; Reeves, W.C. 1991: HTLV-II endemicity among Guaymi Indians in Panama. New England Journal of Medicine 324(8): 565
Kira, J.; Koyanagi, Y.; Hamakado, T.; Itoyama, Y.; Yamamoto, N.; Goto, I. 1991: HTLV-Ii in patients with HTLV-I-associated myelopathy. Lancet 338(8758): 64-65
Zella, D.; Mori, L.; Sala, M.; Ferrante, P.; Casoli, C.; Magnani, G.; Achilli, G.; Cattaneo, E.; Lori, F.; Bertazzoni, U. 1990: HTLV-Ii infection in Italian drug abusers. Lancet 336(8714): 575-576
Parry, C.M.; Harries, A.D.; Beeching, N.J.; Shaw, I.M.; Mutton, K.J.; McAlpine, L.; Tosswill, J.H.; Tuke, P.W.; Garson, J.A. 1991: HTLV-Ii infection in a Liverpool intravenous drug user. Journal of Infection 23(3): 337-339
Rosenblatt, J.D.; Cann, A.J.; Slamon, D.J.; Smalberg, I.S.; Shah, N.P.; Fujii, J.; Wachsman, W.; Chen, I.S. 1988: HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes. Science 240(4854): 916-919
Bennett, J.A. 1985: HTLV-IIi AIDS link. American Journal of Nursing 85(10): 1086-1089
Watanabe, J. 1988: HTLV-IIi Bioenzabead Test Kit (Litton) for the detection of HIV antibodies. Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 78: 51-54
Pepose, J.S.; Pardo, F.S.; Donegan, E.; Quinn, T.C. 1986: HTLV-IIi ELISA testing of cadaveric sera to screen potential organ transplant donors. JAMA 256(7): 864
De Rossi, A.; Gassa, O.D.; del Mistro, A.; Faulkner Valle, G.; Bianchi, L.C. 1986: HTLV-IIi and HTLV-i infection in populations at risk in the Veneto region of Italy. European Journal of Cancer and Clinical Oncology 22(4): 411-418
Norman, C. 1985: HTLV-IIi and LAV: similar, or identical?. Science 230(4726): 643
Anonymous 1985: HTLV-III and blood donors. Lancet 1(8433): 856
Kress, H.G.; Sefrin, P. 1986: HTLV-III and cardiopulmonary resuscitation. Deutsche Medizinische Wochenschrift 111(5): 198
Thomas, C.S.; Toone, B.K.; el Komy, A.; Harwin, B.; Farthing, C.P. 1985: HTLV-IIi and psychiatric disturbance. Lancet 2(8451): 395-396
Gallo, R.C.; Sarngadharan, M.G.; Popovic, M.; Shaw, G.M.; Hahn, B.; Wong-Staal, F.; Robert-Guroff, M.; Zaki Salahuddin, S.; Markham, P.D. 1986: HTLV-IIi and the etiology of AIDS. Progress in Allergy 37: 1-45
Anonymous 1986: HTLV-III and vacuolar myelopathy. New England Journal of Medicine 315(1): 62-63
Kessler, H.; Chase, R.; Harris, A.; Jensen, D.; Levin, S. 1985: HTLV-IIi antibodies after hepatitis B vaccination. Lancet 1(8444): 1506-1507
Piszkiewicz, D. 1987: HTLV-III antibodies after immune globulin. JAMA 257(3): 316
Baselga, J.M.; Buti, M.; Esteban, R.; Tusell, J.; Vila, M.; Guardia, J. 1986: HTLV-IIi antibodies and Christmas disease. Lancet 1(8488): 1033
Zenz, W.; Muntean, W.; Teubl, I.; Beaufort, F.; Heinz, F.X. 1987: HTLV-IIi antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-IIi antibodies in hemophilic children and their relatives living in the same household. Padiatrie und Padologie 22(1): 33-41
Vogt, M.; Lüthy, R.; Ferber, T.; Ledergerber, B.; Schüpbach, J.; Täuber, M.; Siegenthaler, W. 1985: HTLV-IIi antibodies and risk factors for healthy homosexuals in Zurich. Schweizerische Medizinische Wochenschrift 115(49): 1777-1778
James, J.J.; Morgenstern, M.A. 1985: HTLV-III antibodies in US Army blood donors in West Germany. JAMA 254(11): 1449
Gray, R.H.; Wawer, M.J. 1985: HTLV-III antibodies in a remote population of eastern Zaire. British Medical Journal 290(6482): 1662
Brettle, R.P.; Davidson, J.; Davidson, S.J.; Gray, J.M.; Inglis, J.M.; Conn, J.S.; Bath, G.E.; Gillon, J.; McClelland, D.B. 1986: HTLV-IIi antibodies in an Edinburgh clinic. Lancet 1(8489): 1099
Rodrigo, J.M.; Serra, M.A.; Aguilar, E.; del Olmo, J.A.; Gimeno, V.; Aparisi, L. 1985: HTLV-IIi antibodies in drug addicts in Spain. Lancet 2(8447): 156-157
Tirelli, U.; Vaccher, E.; Sorio, R.; Carbone, A.; Monfardini, S. 1986: HTLV-IIi antibodies in drug-addicted prostitutes used by US soldiers in Italy. JAMA 256(6): 711-712
Jones, P.; Hamilton, P. 1985: HTLV-IIi antibodies in haematology staff. Lancet 1(8422): 217
Grabensee, B.; Heering, P.; Heinzler, P.; Passlick, J.; Scheid, A. 1986: HTLV-IIi antibodies in hemodialysis patients and following kidney transplantation. Deutsche Medizinische Wochenschrift 111(41): 1580-1581
Schaefer, K.; Asmus, G.; Hüfler, M.; von Herrath, D. 1986: HTLV-IIi antibodies in hemodialysis patients--a consequence of blood transfusions?. Klinische Wochenschrift 64(13): 621-622
Steele, D.R. 1986: HTLV-IIi antibodies in human immune gamma-globulin. JAMA 255(5): 609
Neumayer, H.H.; Wagner, K.; Kresse, S. 1986: HTLV-IIi antibodies in patients with kidney transplants or on haemodialysis. Lancet 1(8479): 497
Ferroni, P.; Geroldi, D.; Galli, C.; Zanetti, A.R.; Cargnel, A. 1985: HTLV-IIi antibody among Italian drug addicts. Lancet 2(8445): 52-53
McVerry, B.A.; Machin, S.J.; Galloway, M.J.; McCarthy, K.; Evans, P.; Barnes, R.M.; Turner, G.C.; Cheingsong-Popov, R.; Tedder, R.S.; Winter, M. 1986: HTLV-IIi antibody and T-cell subset ratios in haemophiliacs and their spouses. British Journal of Haematology 63(2): 347-352
Galvao-Castro, B.; Pereira, M.S. 1986: HTLV-IIi antibody in Brazilian Indians. Lancet 1(8487): 976
Anonymous 1986: HTLV-III antibody in East Africa. New England Journal of Medicine 315(4): 259-260
Peutherer, J.F.; Edmond, E.; Simmonds, P.; Dickson, J.D.; Bath, G.E. 1985: HTLV-IIi antibody in Edinburgh drug addicts. Lancet 2(8464): 1129-1130
Mortimer, P.P.; Vandervelde, E.M.; Jesson, W.J.; Pereira, M.S.; Burkhardt, F. 1985: HTLV-IIi antibody in Swiss and English intravenous drug abusers. Lancet 2(8452): 449-450
Gilden, R.V.; Arthur, L.O.; Robey, W.G.; Kelliher, J.C.; Graham, C.E.; Fischinger, P.J. 1986: HTLV-IIi antibody in a breeding chimpanzee not experimentally exposed to the virus. Lancet 1(8482): 678-679
Gocke, D.J.; Raska, K.; Pollack, W.; Schwartzer, T. 1986: HTLV-IIi antibody in commercial immunoglobulin. Lancet 1(8471): 37-38
Follett, E.A.; McIntyre, A.; O'Donnell, B.; Clements, G.B.; Desselberger, U. 1986: HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet 1(8478): 446-447
Tor, J.; Muga, R.; Argelagues, E.; Rey-Joly, C.; Foz, M.; Ribas-Mundó, M. 1986: HTLV-IIi antibody in intravenous drug abusers of metropolitan Barcelona, Spain. Archives of Internal Medicine 146(4): 805
Hernandez, J.M.; Argelagués, E.; Canivell, M. 1985: HTLV-IIi antibody in paid plasma donors in Spain. Lancet 1(8442): 1389
Anonymous 1985: HTLV-III antibody in prostitutes. Lancet 2(8469-70): 1424
Madhok, R.; Melbye, M.; Lowe, G.D.; Forbes, C.D.; Froebel, K.S.; Bodner, A.J.; Biggar, R.J. 1985: HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84. Lancet 1(8427): 524-525
Hunsmann, G. 1985: HTLV-IIi antibody positive blood donors. Lancet 1(8439): 1223
Buchanan, D.J.; Downing, R.G.; Tedder, R.S. 1986: HTLV-IIi antibody positivity in Zambian copper belt. Lancet 1(8473): 155
Paschelke, G.; Altvater-Kremer, G.; Meyer, W.D.; Kremer, H. 1987: HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a North-German drug clinic. Klinische Wochenschrift 65(1): 22-26
Seidl, S.; Kühnl, P. 1985: HTLV-IIi antibody screening in German blood donors. Lancet 1(8436): 1047
Madhok, R.; Melbye, M.; Lowe, G.D.; Forbes, C.D.; Froebel, K.S.; Bodner, A.J.; Biggar, R.J. 1985: HTLV-IIi antibody in sequential plasma samples: from haemophiliacs 1974-84. Lancet 1(8427): 524-525
Moffat, E.H.; Bloom, A.L.; Mortimer, P.P. 1985: HTLV-IIi antibody status and immunological abnormalities in haemophilic patients. Lancet 1(8434): 935
Muntean, W.; Zenz, W.; Zaunschirm, W.; Teubl, I.; Heinz, F.X. 1986: HTLV-IIi antibody status in household contacts of seropositive hemophiliacs. Blood 67(6): 1780-1781
Giroldi, L.; Hamel, E.; Yamasaki, H. 1986: 1-Oleoyl 2-acetyl glycerol inhibits differentiation of TPA-sensitive but not of TPA-resistant Friend cells. Carcinogenesis 7(7): 1183-1186
Chang, R.S.; Chan, R.C.; French, G.L.; Leong, S.; Mak, K.H.; Carlson, J.R.; Yee, J.; Gardner, M.B. 1986: HTLV-IIi antibody testing in Hong Kong. JAMA 256(1): 41
Nájera, R.; Echevarría, J.M.; Varela, J.M.; de Andrés, R.; de la Loma, A. 1985: HTLV-IIi antibody testing in Spain. Lancet 2(8458): 783
Schiff, I.; Correia, B.; Ravnikar, V.A.; Schur, P.H. 1985: HTLV-III antibody testing in sperm donors. New England Journal of Medicine 312(25): 1638
Orskov Lindhardt, B.; Ulrich, K.; Ryder, L.; Dickmeiss, E.; Sørensen, H.; Jørgensen, J.; Jersild, C.; Grunnet, N. 1986: HTLV-IIi antibody testing in three Danish blood banks. Vox Sanguinis 51(Suppl 1): 9-14
Yomtovian, R. 1986: HTLV-III antibody testing: the false-negative rate. JAMA 255(5): 609
Barclay, G.R.; Hopcroft, W.; McClelland, D.B. 1986: What is an "equivocal" negative HTLV-IIi antibody test in blood donors?. Lancet 1(8486): 912-913
Crowl, R.; Ganguly, K.; Gordon, M.; Conroy, R.; Schaber, M.; Kramer, R.; Shaw, G.; Wong-Staal, F.; Reddy, E.P. 1985: HTLV-IIi env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients. Cell 41(3): 979-986
Ginzburg, H.M.; Weiss, S.H.; MacDonald, M.G.; Hubbard, R.L. 1985: HTLV-IIi exposure among drug users. Cancer Research 45(9 Suppl): 4605s-4608s
Saviteer, S.M.; White, G.C.; Cohen, M.S.; Jason, J. 1985: HTLV-III exposure during cardiopulmonary resuscitation. New England Journal of Medicine 313(25): 1606-1607
Feinberg, M.B.; Jarrett, R.F.; Aldovini, A.; Gallo, R.C.; Wong-Staal, F. 1986: HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46(6): 807-817
Biberfeld, P.; Chayt, K.J.; Marselle, L.M.; Biberfeld, G.; Gallo, R.C.; Harper, M.E. 1986: HTLV-IIi expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. American Journal of Pathology 125(3): 436-442
Kramer, R.A.; Schaber, M.D.; Skalka, A.M.; Ganguly, K.; Wong-Staal, F.; Reddy, E.P. 1986: HTLV-IIi gag protein is processed in yeast cells by the virus pol-protease. Science 231(4745): 1580-1584
Cuxart, M.; Salas, M.; Aubia, J.; Lloveras, J. 1986: HTLV-III in patients in a hemodialysis program. Medicina Clinica 86(14): 611
Fujikawa, L.S.; Salahuddin, S.Z.; Ablashi, D.; Palestine, A.G.; Masur, H.; Nussenblatt, R.B.; Gallo, R.C. 1986: HTLV-IIi in the tears of AIDS patients. Ophthalmology 93(12): 1479-1481
Antin, J.H.; Smith, B.R.; Ewenstein, B.M.; Arceci, R.J.; Lipton, J.M.; Page, P.L.; Rappeport, J.M. 1986: HTLV-IIi infection after bone marrow transplantation. Blood 67(1): 160-163
Tirelli, U.; Vaccher, E.; Carbone, A.; Diodato, S.; Sorio, R.; Bosio, R.; Tamburlini, R.; Crotti, D.; Crovatto, M.; De Paoli, P. 1986: HTLV-IIi infection among 315 intravenous drug abusers: seroepidemiological, clinical, and pathological findings. Aids Research 2(4): 325-334
Weiss, S.H.; Saxinger, W.C.; Rechtman, D.; Grieco, M.H.; Nadler, J.; Holman, S.; Ginzburg, H.M.; Groopman, J.E.; Goedert, J.J.; Markham, P.D. 1985: HTLV-III infection among health care workers. Association with needle-stick injuries. JAMA 254(15): 2089-2093
Hattori, T.; Uchida, T.; Matsuoka, M.; Takatsuki, K.; Ikematsu, S.; Fukutake, K. 1985: HTLV-III infection and epitope recognition by OKT4 monoclonal antibody. New England Journal of Medicine 313(24): 1543-1544
Rasokat, H. 1986: HTLV-IIi infection and the central nervous system. Zeitschrift für Hautkrankheiten 61(6): 333-334
Tucker, J.; Ludlam, C.A.; Craig, A.; Philp, I.; Steel, C.M.; Tedder, R.S.; Cheingsong-Popov, R.; Macnicol, M.F.; McClelland, D.B.; Boulton, F.E. 1985: HTLV-IIi infection associated with glandular-fever-like illness in a haemophiliac. Lancet 1(8428): 585
Heckmann, F.; Klingler, K.W. 1986: HTLV-IIi infection caused by blood transfusion. Medizinische Klinik 81(17): 583-584
Neumann, P.W.; Benning, B.J.; Robinson, D.G.; Gilmore, N.; O'Shaughnessy, M.V. 1986: HTLV-IIi infection in Canada in 1985. Cmaj: Canadian Medical Association Journal 135(5): 477-480
Shaw, G.M.; Harper, M.E.; Hahn, B.H.; Epstein, L.G.; Gajdusek, D.C.; Price, R.W.; Navia, B.A.; Petito, C.K.; O'Hara, C.J.; Groopman, J.E. 1985: HTLV-IIi infection in brains of children and adults with AIDS encephalopathy. Science 227(4683): 177-182
Biberfeld, G.; Böttiger, B.; Karlsson, A.; Sandström, E.; Morfeldt-Månsson, L.; Blombäck, M.; Nilsson, I.M.; Wiechel, B.; Saxinger, C.; Gallo, R. 1985: HTLV-IIi infection in homosexuals and hemophiliacs in Sweden. Cancer Research 45(9 Suppl): 4609s-4611s
L'age-Stehr, J.; Schwarz, A.; Offermann, G.; Langmaack, H.; Bennhold, I.; Niedrig, M.; Koch, M.A. 1985: HTLV-III infection in kidney transplant recipients. Lancet 2(8468): 1361-1362
Unsworth, P.F. 1985: HTLV-IIi infection in spouses of haemophiliacs. British Medical Journal 291(6500): 966
Becker, W.B. 1986: HTLV-III infection in the RSA. South African Medical Journal: 26-27
Salahuddin, S.Z.; Ablashi, D.V.; Hunter, E.A.; Gonda, M.A.; Sturzenegger, S.; Markham, P.D.; Gallo, R.C. 1987: HTLV-IIi infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens. International Journal of Cancer 39(2): 198-202
Partanen, P. 1986: HTLV-IIi infection serologic diagnosis. Suomen Hammaslaakarilehti 33(10): 610-613
Pien, F.D. 1986: HTLV-III infection. A clinical approach to diagnosis and treatment of the 'AIDS virus'. Postgraduate Medicine 80(4): 135-7 140-2
Rasokat, H. 1986: HTLV-IIi infection. new routes of transmission?. Zeitschrift für Hautkrankheiten 61(8): 509-510
Biberfeld, G.; Böttiger, M.; Biberfeld, P. 1985: HTLV-IIi infections and AIDS--current epidemiology and serology. Lakartidningen 82(20): 1867-1870
Freedman, J.M. 1987: HTLV-IIi is now HIV. Anesthesiology 67(1): 145-146
Mann, D.L.; Lasane, F.; Popovic, M.; Arthur, L.O.; Robey, W.G.; Blattner, W.A.; Newman, M.J. 1987: HTLV-IIi large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. Journal of Immunology 138(8): 2640-2644
Gilden, R.V.; Gonda, M.A.; Sarngadharan, M.G.; Popovic, M.; Gallo, R.C. 1986: HTLV-III legend correction. Science 232(4748): 307
Kopp, W.; Dangl-Erlach, E. 1986: HTLV-IIi monitoring in prostitutes in Vienna. Wiener Klinische Wochenschrift 98(20): 695-698
Robert-Guroff, M.; Giardina, P.J.; Robey, W.G.; Jennings, A.M.; Naugle, C.J.; Akbar, A.N.; Grady, R.W.; Hilgartner, M.W. 1987: HTLV-IIi neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia. Journal of Immunology 138(11): 3731-3736
Duncombe, A.S.; Savidge, G.F.; Craske, J. 1986: HTLV-IIi related illness and Christmas disease. Lancet 1(8478): 447-448
Mannis, M.J.; Brightbill, F.S.; Moore, T.J. 1986: HTLV-IIi screening by eye banks. American Journal of Ophthalmology 101(3): 385-386
White, G.C.; Matthews, T.J.; Weinhold, K.J.; Haynes, B.F.; Cromartie, H.L.; McMillan, C.W.; Bolognesi, D.P. 1986: HTLV-IIi seroconversion associated with heat-treated factor VIIi concentrate. Lancet 1(8481): 611-612
Morell, A.; Barandun, S.; Locher, G. 1986: HTLV-III seroconversion in a homosexual patient with common variable immunodeficiency. New England Journal of Medicine 315(7): 456-457
Bayley, A.C.; Downing, R.G.; Cheingsong-Popov, R.; Tedder, R.S.; Dalgleish, A.G.; Weiss, R.A. 1985: HTLV-IIi serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet 1(8425): 359-361
Gill, J.C.; Menitove, J.E.; Anderson, P.R.; Casper, J.T.; Devare, S.G.; Wood, C.; Adair, S.; Casey, J.; Scheffel, C.; Montgomery, R.R. 1986: HTLV-IIi serology in hemophilia: relationship with immunologic abnormalities. Journal of Pediatrics 108(4): 511-516
Pont, J.; Neuwald, C.; Kunz, C.; Werdenich, W. 1986: HTLV-IIi serology, epidemiology and clinical aspects of imprisoned I.v. drug-dependent males in Austria. Wiener Klinische Wochenschrift 98(14): 454-457
Moore, J.D.; Cone, E.J.; Alexander, S.S. 1986: HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?. New England Journal of Medicine 314(21): 1387-1388
Giudizi, M.G.; Biagiotti, R.; Almerigogna, F.; Mazzetti, M.; Alessi, A.; Massai, G.; Longo, G.; Scano, G.; Morfini, M.; Romagnani, S. 1986: HTLV-IIi seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes. Scandinavian Journal of Haematology 36(2): 198-202
Shannon, B.T.; Roach, J.; Cheek-Luten, M.; Ruymann, F.B. 1986: HTLV-IIi status and abnormalities in T lymphocyte distribution in children with hemophilia a. Diagnostic Immunology 4(1): 37-42
Goldsmith, M.F. 1985: HTLV-IIi testing of donor blood imminent; complex issues remain. JAMA 253(2): 173-175; 179-181
Grouse, L.D. 1985: HTLV-IIi transmission. JAMA 254(15): 2130-2131
Kaplan, J.E.; Spira, T.J.; Feorino, P.M.; Warfield, D.T.; Fishbein, D.B. 1985: HTLV-III viremia in homosexual men with generalized lymphadenopathy. New England Journal of Medicine 312(24): 1572-1573
Black, P.H. 1985: HTLV-III, AIDS, and the brain. New England Journal of Medicine 313(24): 1538-1540
Bloom, A.L.; Forbes, C.D.; Rizza, C.R. 1985: HTLV-III, haemophilia, and blood transfusion. British Medical Journal 290(6485): 1901-1902
Velasco, M.; Sepúlveda, C. 1985: HTLV-III, virus hepatitis B and CMV in Chilean homosexuals. Revista Medica de Chile 113(6): 587-589
Bellotto, R.; Morelli, R.; Amabile, G.; Gaini, R. 1987: HTLV-III-induced neuropathy: assessment by means of auditory brainstem evoked responses (ABR). Journal of Experimental Pathology 3(4): 713-722
Kato, T.; Dembitzer, H.M.; Hirano, A.; Llena, J.F. 1987: HTLV-III-like particles within a cell process surrounded by a myelin sheath in an AIDS brain. Acta Neuropathologica 73(3): 306-308
Kroegel, C.; Hess, G.; Meyer zum Büschenfelde, K.H. 1986: HTLV-III/LAV and resuscitation. Deutsche Medizinische Wochenschrift 111(12): 476-477
Streicher, H.Z.; Joynt, R.J. 1986: HTLV-III/LAV and the monocyte/macrophage. JAMA 256(17): 2390-2391
Gallo, R.C.; Robert-Guroff, M.; Wong-Staal, F.; Reitz, M.S.; Arya, S.K.; Streicher, H.Z. 1987: HTLV-III/LAV and the origin and pathogenesis of AIDS. International Archives of Allergy and Applied Immunology 82(3-4): 471-475
Volsky, D.J.; Wu, Y.T.; Sinangil, F.; Goldsmith, J.C. 1986: HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study. Aids Research 2(1): 51-61
Girón, J.A. 1986: HTLV-III/LAV antibodies in contacts of hemophiliacs. JAMA 255(23): 3246
Kaeser, A. 1986: HTLV-III/LAV antibodies in gamma globulin preparations for intravenous use. Deutsche Medizinische Wochenschrift 111(33): 1263
Jason, J.M.; McDougal, J.S.; Dixon, G.; Lawrence, D.N.; Kennedy, M.S.; Hilgartner, M.; Aledort, L.; Evatt, B.L. 1986: HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. JAMA 255(2): 212-215
Lawrence, D.N.; Jason, J.M.; Bouhasin, J.D.; McDougal, J.S.; Knutsen, A.P.; Evatt, B.L.; Joist, J.H. 1985: HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients. Blood 66(3): 703-705
Peterman, T.A.; Lang, G.R.; Mikos, N.J.; Solomon, S.L.; Schable, C.A.; Feorino, P.M.; Britz, J.A.; Allen, J.R. 1986: HTLV-III/LAV infection in hemodialysis patients. JAMA 255(17): 2324-2326
Shaffer, D.; Pearl, R.H.; Jenkins, R.L.; Hammer, S.M.; Dzik, W.J.; Groopman, J.E.; Benotti, P.N.; Monaco, A.P. 1987: HTLV-III/LAV infection in kidney and liver transplantation. Transplantation Proceedings 19(1 Part 3): 2176-2178
Lange, J.M.; van den Berg, H.; Dooren, L.J.; Vossen, J.M.; Kuis, W.; Goudsmit, J. 1986: HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins. Journal of Infectious Diseases 154(1): 171-174
Mirra, S.S.; Anand, R.; Spira, T.J. 1986: HTLV-III/LAV infection of the central nervous system in a 57-year-old man with progressive dementia of unknown cause. New England Journal of Medicine 314(18): 1191-1192
Tramont, E.C.; Redfield, R.; Burke, D.; Takafuji, E.T.; Wright, C.; Moore, W. 1987: HTLV-III/LAV infections in the military. Military Medicine 152(2): 105-106
Stricof, R.L.; Morse, D.L. 1986: HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury. New England Journal of Medicine 314(17): 1115
Tenner-Racz, K.; Racz, P.; Bofill, M.; Schulz-Meyer, A.; Dietrich, M.; Kern, P.; Weber, J.; Pinching, A.J.; Veronese-Dimarzo, F.; Popovic, M. 1986: HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. American Journal of Pathology 123(1): 9-15
James, J.J.; Morgenstern, M.A.; Hatten, J.A. 1986: HTLV-III/LAV-antibody-positive soldiers in Berlin. New England Journal of Medicine 314(1): 55-56
Putney, S.D.; Matthews, T.J.; Robey, W.G.; Lynn, D.L.; Robert-Guroff, M.; Mueller, W.T.; Langlois, A.J.; Ghrayeb, J.; Petteway, S.R.; Weinhold, K.J. 1986: HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234(4782): 1392-1395
McFadden, T.; Jason, J.M.; Feorino, P. 1986: HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs. JAMA 255(13): 1702
Miller, D.; Jeffries, D.J.; Green, J.; Harris, J.R.; Pinching, A.J. 1986: HTLV-III: should testing ever be routine?. British Medical Journal 292(6525): 941-943
Fine, R.M. 1988: HTLV-V: a new human retrovirus associated with cutaneous T-cell lymphoma (mycosis fungoides). International Journal of Dermatology 27(7): 473-474
Manzari, V.; Gismondi, A.; Barillari, G.; Morrone, S.; Modesti, A.; Albonici, L.; De Marchis, L.; Fazio, V.; Gradilone, A.; Zani, M. 1987: HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. Science 238(4833): 1581-1583
Lennert, K.; Kikuchi, M.; Sato, E.; Suchi, T.; Stansfeld, A.G.; Feller, A.C.; Hansmann, M.L.; Müller-Hermelink, H.K.; Gödde-Salz, E. 1985: HTLV-positive and -negative T-cell lymphomas. Morphological and immunohistochemical differences between European and HTLV-positive Japanese T-cell lymphomas. International Journal of Cancer 35(1): 65-72
Brosset, C.; Hovette, P.; Raphenon, G.; Debonne, J.M.; Dano, P.; Laroche, R. 1991: HTLV1 and coinfections. Medecine Tropicale: Revue du Corps de Sante Colonial 51(4): 399-406
Gallo, R.C. 1986: HTLV: the family of human T-lymphotropic retroviruses and their role in leukemia and AIDS. Medical Oncology and Tumor PharmacoTherapy 3(3-4): 265-267
Ferrante, P.; Seresella, M.; Cocuzza, C.E.; Caputo, D.; Cattaneo, E.; Achilli, G.; Cazzullo, C.L. 1990: HTLVi antibodies in multiple sclerosis and other neurological diseases. Acta Neurologica 12(1): 95-99
Siepmann, J.P.; Bachman, J.W. 1987: HTN-APT: computer aid in hypertension management. Journal of Family Practice 24(3): 313-316
Yamamoto, O.; Yokoro, K.; Seyama, T.; Kinomura, A.; Nomura, T. 1990: HTO oral administration in mice. I: Threshold dose rate for haematopoietic death. International Journal of Radiation Biology 57(3): 543-549
Norman, B.A. 1987: HTR polymer bone-grafting material: a clinical survey of 647 cases. Compendium 8(10): 821-822
Yukna, R.A. 1990: HTR polymer grafts in human periodontal osseous defects. I. 6-month clinical results. Journal of Periodontology 61(10): 633-642
Leake, D. 1988: HTR polymer: present and future applications. Compendium . Suppl 10: S328-S329
Frame, P.S.; Werth, P.L. 1992: HTRAK, a computerized health maintenance tracking system for primary care. Proceedings. Symposium on Computer Applications in Medical Care 1992: 833-834
Bonnefoy, E.; Rouvière-Yaniv, J. 1991: HU and IHF, two homologous histone-like proteins of Escherichia coli, form different protein-DNA complexes with short DNA fragments. EMBO Journal 10(3): 687-696
Boubrik, F.; Bonnefoy, E.; Rouvière-Yaniv, J. 1991: HU and IHF: similarities and differences. in Escherichia coli, the lack of HU is not compensated for by IHF. Research in Microbiology 142(2-3): 239-247
Goshima, N.; Kohno, K.; Imamoto, F.; Kano, Y. 1990: HU-1 mutants of Escherichia coli deficient in DNA binding. Gene 96(1): 141-145
Irie, G.; Miyasaka, K. 1991: HU-PACS. 10 months experience. Computer Methods and Programs in Biomedicine 36(2-3): 71-75
McKusick, V.A. 1989: HUGO news. The Human Genome Organisation: history, purposes, and membership. Genomics 5(2): 385-387
Roberts, L. 1991: HUGO takes on role as marriage broker. Science 254(5034): 932
Nickoloff, B.J.; Mitra, R.S.; Shimizu, Y.; Barker, J.N.; Karabin, G.; Stoof, T.; Stoolman, L.M. 1992: HUT 78 T cells bind to noncytokine-stimulated keratinocytes using a non-CD18-dependent adhesion pathway. American Journal of Pathology 140(6): 1365-1374
Chatterley, A. 1990: HV job-sharing. Community Outlook 1990: 43-44
Carrieri, P.; Mandarini, A.; Campanella, G. 1975: HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data. Acta Neurologica 30(5): 449-454
Anonymous 1986: HVA code of practice for health visitors in relation to the international code of marketing of breastmilk substitutes. Health Visitor 59(10): 317-318
Potrykus, C. 1989: HVA wins fair grades for sickle cell specialists. Health Visitors' Association. Health Visitor 62(12): 360
Dietz, E.R. 1988: HVE tips: maximizing high-velocity suction. Dental Assistant 57(6): 4-6
Takasaka, T. 1988: HVEM (high-voltage electron microscopy) and computer-assisted 3D reconstruction. Hokkaido Journal of Medical Science 63(4): 473-477
Royer, S.M.; Kinnamon, J.C. 1991: HVEM serial-section analysis of rabbit foliate taste buds: I. Type III cells and their synapses. Journal of Comparative Neurology 306(1): 49-72
Luker, K. 1979: HVs--question or challenge?. Community Outlook 1979: 201
Clark, J. 1979: HVs--starting research. Community Outlook 1979: 203
Smith, B. 1987: HWGA reports on: the status of physician assistant's practice in Kentucky. Kentucky Nurse 35(4): 1
Miller, P.L.; Blumenfrucht, S.J.; Rose, J.R.; Rothschild, M.; Swett, H.A.; Weltin, G.; Mars, N.J. 1987: HYDRA: a knowledge acquisition tool for expert systems that critique medical workup. Medical Decision Making: An International Journal of the Society for Medical Decision Making 7(1): 12-21
Hamori, E.; Varga, G.; LaGuardia, J.J. 1989: HYLAS: program for generating H curves (abstract three-dimensional representations of long DNA sequences). Computer applications in the biosciences: CABIOS 5(4): 263-269
Benton, E.V.; Peterson, D.D.; Marenny, A.M.; Popov, V.I. 1978: HZE particle radiation studies aboard Kosmos 782. Health Physics 35(5): 643-648
Oldendorf, W.H.; Braun, L.D. 1976: H] Tryptamine and 3H-water as diffusible internal standards for measuring brain extraction of radio-labeled substances following carotid injection. Brain Research 113(1): 219-224
Sarai, Y.; Kondo, I. 1975: Ha antibody against exfoliatin A and B (with special reference to the sera of clinical patients and normal controls). Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 30(1): 222
Hackstein, P. 1991: Ha-Dent-Unilock--half automatic titanium bolt. Das Dental-Labor. le Laboratoire Dentaire. Dental Laboratory 39(12): 1801-1805
Kovary, K.; Armelin, M.C.; Armelin, H.A. 1989: Ha-Ras-1 oncogene dosage differentially affects Balb/3T3 cells' growth factor requirement and tumorigenicity. Oncogene Research 4(1): 55-64
Ledermann, P.D. 1991: Ha-Ti-Step-Screw implants construction principles. Phillip Journal 8(6): 363-365
Andres, A.C.; van der Valk, M.A.; Schönenberger, C.A.; Flückiger, F.; LeMeur, M.; Gerlinger, P.; Groner, B. 1988: Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes and Development 2(11): 1486-1495
Theodorescu, D.; Cornil, I.; Sheehan, C.; Man, M.S.; Kerbel, R.S. 1991: Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells. Cancer Research 51(16): 4486-4491
Lu, S.J.; Archer, M.C. 1992: Ha-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 89(3): 1001-1005
Andres, A.C.; Schönenberger, C.A.; Groner, B.; Hennighausen, L.; LeMeur, M.; Gerlinger, P. 1987: Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 84(5): 1299-1303
Cosma, G.N.; Wirgin, I.I.; Marchok, A.C.; Garte, S.J. 1990: Ha-ras oncogene mutations in cell lines derived from rat tracheal implants exposed in vivo to 7,12-dimethylbenz[a]anthracene. Molecular Carcinogenesis 3(5): 258-263
Tahara, E.; Yasui, W.; Taniyama, K.; Ochiai, A.; Yamamoto, T.; Nakajo, S.; Yamamoto, M. 1986: Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. Japanese Journal of Cancer Research: Gann 77(6): 517-522
Oku, N.; Shimada, K.; Itoh, H. 1989: Ha-ras oncogene product in human oral squamous cell carcinoma. Kobe Journal of Medical Sciences 35(5-6): 277-286
O'Briant, K.; Chrysson, N.; Hunter, V.; Tyson, F.; Tanner, M.; Daly, L.; George, S.L.; Berchuck, A.; Soper, J.; Fowler, W. 1992: Ha-ras polymorphisms in epithelial ovarian cancer. Gynecologic Oncology 45(3): 299-302
Manne, V.; Bekesi, E.; Kung, H.F. 1985: Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity. Proceedings of the National Academy of Sciences of the United States of America 82(2): 376-380
Ryberg, D.; Tefre, T.; Ovrebø, S.; Skaug, V.; Stangeland, L.; Naalsund, A.; Baera, R.; Børresen, A.L.; Haugen, A. 1990: Ha-ras-1 alleles in Norwegian lung cancer patients. Human Genetics 86(1): 40-44
Ceccherini-Nelli, L.; De Re, V.; Viel, A.; Molaro, G.; Zilli, L.; Clemente, C.; Boiocchi, M. 1987: Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. British Journal of Cancer 56(1): 1-5
Barrett, C.B.; Schroetke, R.M.; Van der Hoorn, F.A.; Nordeen, S.K.; Maller, J.L. 1990: Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways. Molecular and Cellular Biology 10(1): 310-315
McEvoy, J.P.; Kamaraju, L.; Nelson, L. 1992: Haase hermeneutics, or, the exegesis of the neuroleptic threshold. Journal of Clinical Psychopharmacology 12(1): 64-65
Olier, B.; Morin, J.P.; Thomas, N.; Fillastre, J.P. 1988: Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin. Pathologie-Biologie 36(6): 795-800
Stewens, J.; Marre, R.; Engelbart, K.; Schulz, E.; Sack, K. 1985: Habekacin: nephrotoxicity, pharmacokinetics and prophylactic efficacy in rats. Arzneimittel-Forschung 35(9): 1440-1446
Tesar, O.; Maydl, K. 1988: Habent sua fata libelli. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 67(1): 57-59
Zallár, A.; Szabó, T.; Szent-Györgyi, A. 1989: Habent sua fata libelli: the adventurous story of Albert Szent-Györgyi's book entitled Studies on Muscle (1945). Acta Physiologica Scandinavica 135(4): 423-424
Yu, L.C.; Han, J.S. 1990: Habenula as a relay in the descending pathway from nucleus accumbens to periaqueductal grey subserving antinociception. International Journal of Neuroscience 54(3-4): 245-251
Aghajanian, G.K.; Wang, R.Y. 1977: Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Research 122(2): 229-242
Clairambault, P.; Pairault, C.; Fasolo, A. 1986: Habenular connections in the brain of the newt, Triturus cristatus carnifex Laurenti. Journal für Hirnforschung 27(1): 111-119
Zagami, M.T.; Montalbano, M.E.; Sabatino, M.; Ferraro, G.; Vella, N.; La Grutta, V. 1989: Habenular effect on hippocampal excitability is not cholinergically-mediated. Pharmacological Research 21(Suppl): 41-42
Sasaki, K.; Suda, H.; Watanabe, H.; Kaneko, S.; Nomura, Y.; Nishino, H.; Ono, T. 1988: Habenular lesion attenuates methamphetamine-induced inhibition of dopamine neuronal activity in the substantia nigra pars compacta of rats. Neuroscience Letters 86(1): 67-71
Du, J.H.; Qiao, J.T. 1990: Habenulopetal catecholaminergic projections in the rat brain: a combined Fluoro-Gold/catecholamine fluorescence study. Brain Research 533(2): 334-337
Kikuchi, I.; Crovato, F.; Rebora, A. 1988: Haber's syndrome and Dowling-Degos disease. International Journal of Dermatology 27(2): 96-97
Heim, R. 1991: Habermas, Freud and rationality. Psychoanalysis as a focus of the theory of communicative interaction. Psyche 45(7): 561-589
Mitchell, R.G. 1975: Habilitation in childhood. Health Bulletin 33(6): 245-248
Broder, H.L.; Smith, F.B.; Strauss, R.P. 1992: Habilitation of patients with clefts: parent and child ratings of satisfaction with appearance and speech. Cleft Palate-Craniofacial Journal: Official Publication of the American Cleft Palate-Craniofacial Association 29(3): 262-267
Christiansen, R.L.; Evans, C.A. 1975: Habilitation of severe craniofacial anomalies--the challenge of new surgical procedures: an NIDR workshop. Cleft Palate Journal 12: 167-176
Frauman, A.C.; Gilman, C. 1979: Habilitation of the pediatric renal transplant patient. Nephrology Nurse 1(5): 15-18; 43
Mitra, S.B. 1979: Habilitation programming for severely retarded adolescents and adults: an experiment in normalization. International Journal of Rehabilitation Research. Internationale Zeitschrift für Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation 2(1): 95-98
Ruud, E. 1992: Habilitation/rehabilitation--young people and adults with congenital or early acquired functional disabilities. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(14): 1867
Bramadat, I.J.; Melvin, C.L. 1987: Habilitation: application of a concept. Clinical Nurse Specialist Cns 1(2): 76-79
Nikano, M. 1985: Habit diseases. Kangogaku Zasshi 49(12): 1344
Mannell, R.C.; Duthie, J.H. 1975: Habit lag: when "automatization" is dysfunctional. Journal of Psychology 89(1st Half): 73-80
Grainger, R.D. 1991: Habit management. American Journal of Nursing 91(2): 14 16
Mierau, H.D.; Haubitz, I.; Völk, W. 1989: Habit patterns in the use of the manual toothbrush. 1. Deutsche Zahnarztliche Zeitschrift 44(11): 836-841
Azrin, N.H.; Peterson, A.L. 1988: Habit reversal for the treatment of Tourette syndrome. Behaviour Research and Therapy 26(4): 347-351
Ouslander, J.G.; Blaustein, J.; Connor, A.; Pitt, A. 1988: Habit training and oxybutynin for incontinence in nursing home patients: a placebo-controlled trial. Journal of the American Geriatrics Society 36(1): 40-46
Gazenko, O.G.; Grigor'ev, A.I.; Meleshko, G.I.; Shepelev, E.Ia. 1990: Habitability and biological life support systems for man. Kosmicheskaia Biologiia i Aviakosmicheskaia Meditsina 24(3): 12-17
Bukharin, E.A.; Kerov, G.V.; Lomov, O.P.; Khokhlin, E.P. 1978: Habitability characteristics of the aircraft carriers of foreign fleets. Voenno-Meditsinskii Zhurnal 7: 89-90
Bagley, S.T. 1985: Habitat association of Klebsiella species. Infection control: IC 6(2): 52-58
Moore, J.C.; Walter, D.E.; Hunt, H.W. 1989: Habitat compartmentation and environmental correlates of food chain length. Science 243(4888): 238-240
Ginsberg, H.S.; Ewing, C.P. 1989: Habitat distribution of Ixodes dammini (Acari: Ixodidae) an Lyme disease spirochetes on Fire Island, New York. Journal of Medical Entomology 26(3): 183-189
Christensen, B. 1977: Habitat preference among amylase genotypes in Asellus aquaticus (Isopoda, Crustacea). Hereditas 87(1): 21-26
Vasil'eva, I.S. 1976: Habitat sites of an Ornithodoros tartakovskyi Ol. (Argasidae) population in southern Tadzhikistan. 3. the relationships of Ornithodoros tartakovskyi Ol. to various types of burrows. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(3): 309-313
Ismail, R. 1979: Habitat--for whom?. Nursing Journal of India 70(5): 117-118
Hagan, C.E.; Kettle, D.S. 1990: Habitats of Culicoides spp. in an intertidal zone of southeast Queensland, Australia. Medical and Veterinary Entomology 4(1): 105-115
Vasil'eva, I.S. 1976: Habitats of Ornithodoros tartakovskyi 01. (Argasidae) in Southern Tadzhikistan. 2. Distribution of O. tartakovskyi along the burrows in the summer. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(2): 204-209
Vasil'eva, I.S. 1976: Habitats of the population of Ornithodoros tartakovskyi ol. (Argasidae) in southern Tadzhikistan. Report 1. Number of ticks in various types of burrows. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(1): 42-49
Rubio Aranda, E.; Ejea Arquillue, M.V.; Sánchez Oriz, E.; Rubio Calvo, E. 1991: Habits and alcohol consumption among Saragossa student population. Revista de Sanidad E Higiene Publica 65(1): 45-52
Hemenway, D.; Solnick, S.J.; Weil, D.S.; Koeck, C.M. 1992: Habits and attitudes of public health students. American Journal of Public Health 82(3): 464
Cooreman, J.; Pretet, S.; Levallois, M.; Marsac, J.; Perdrizet, S. 1988: Habits and attitudes towards smoking among the health staff of a large Parisian hospital. Bulletin of the International Union Against Tuberculosis and Lung Disease 63(2): 20
Jafarey, N.A.; Mahmood, Z.; Zaidi, S.H. 1977: Habits and dietary pattern of cases of carcinoma of the oral cavity and oropharynx. Jpma. Journal of the Pakistan Medical Association 27(6): 340-343
Talamini, R.; Bidoli, E.; Serraino, D.; Barra, S.; Franceschi, S.; Bollini, P. 1989: Habits and opinions about cigarette smoking among medical, nursing and technico-administrative staff at the Magenta Hospital (Local Health Unit no. 72). Epidemiologia E Prevenzione 11(38): 35-40
Andersen, H.J. 1992: Habits and rituals. Danish Medical Bulletin 39(3): 273-274
Sánchez Cruz, O. 1991: Habits of abnormal pressure (finger) (6th of 12 articles). Practica Odontologica 12(7): 43-45
Holland-Moritz, R. 1975: Habits of dental hygiene--findings in mouth and dentition. a comparative study in soldiers of the federal army. Zahnarztliche Mitteilungen 65(22): 1049-1052
Brohult, J.; Hedman, P.; Rombo, L.; Sirleaf, V.; Bengtsson, E. 1979: Habits of malaria chemoprophylaxis and an analysis of breakdowns in a West African mining town. Annals of Tropical Medicine and Parasitology 73(4): 327-331
Hansen, D.J.; Tishelman, A.C.; Hawkins, R.P.; Doepke, K.J. 1990: Habits with potential as disorders. Prevalence, severity, and other characteristics among college students. Behavior Modification 14(1): 66-80
Treffers, P.E.; Spiekerman, J.C. 1991: Habitual abortion and a congenital disorder of the uterus. Nederlands Tijdschrift Voor Geneeskunde 135(12): 497-500
Mamedalieva, N.M.; Elizarova, I.P.; Razumovskaia, I.N.; Kaz'min, A.M. 1990: Habitual abortion as a high risk factor for the formation of perinatal pathology and disorders of psychomotor development in children. Vestnik Akademii Meditsinskikh Nauk SSSR 5: 31-33
Madland, T.M.; Skjeldestad, F.E.; Brabrand, J.; Berg, E. 1988: Habitual abortion. An epidemiological study in the county of Sør-Trøndelag in 1974, 1979 and 1984. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(17-18): 1393-1394
Elizondo Elizondo, F.; González Briseño, M.R.; García Martínez, A.; Hernández Ayup, S.; González de León, E. 1978: Habitual abortion. Analytic study of 57 cases. Ginecologia y Obstetricia de Mexico 43(259): 311-316
Neumann, L. 1986: Habitual anterior dislocation of the shoulder treated by the Bristow-Latarjet method. Ugeskrift for Laeger 148(24): 1460-1462
Forestier, E. 1977: Habitual bed posture and incidence of otitis in infants. Lakartidningen 74(20): 2022
Desai, J.H.; Shah, V.K.; Daruwala, D.F.; Gandhi, M.J. 1986: Habitual cathartic abuse--cause of acquired Q-T prolongation. Journal of the Association of Physicians of India 34(5): 389
Antropov, V.K. 1976: Habitual dislocation of the arm. Fel'dsher i Akusherka 41(3): 25-27
Schmid, F. 1991: Habitual dislocation of the elbow in children. Unfallchirurgie 17(1): 34-38
Heras, J.; Hidalgo, A.; Garcia Mata, S.; Martinez Grande, M. 1988: Habitual dislocation of the hip. International Orthopaedics 12(1): 89-91
Gregosiewicz, A.; Stołecka, D.; Okoński, M.; Stazka-Gregosiewicz, E. 1988: Habitual dislocation of the hip joint and patella in a child with congenital analgesia syndrome. Chirurgia Narzadow Ruchu i Ortopedia Polska 53(1): 50-53
Sharma, S.V. 1990: Habitual dislocation of the patella. International Orthopaedics 14(1): 21-23
Sebastiani, C.; Bardelli, M. 1976: Habitual dislocation of the patella. (Revision of cases treated using the Putti-Goebbel method) Synopsis of the subject. Archivio "putti" di Chirurgia Degli Organi di Movimento 27: 181-197
Perazzini, P.G.; Iucopilla, N.; Zorzi, C. 1985: Habitual dislocation of the peroneal tendons (a contribution to surgical technic). Archivio "putti" di Chirurgia Degli Organi di Movimento 35: 281-283
Drachuk, P.S. 1988: Habitual dislocation of the shoulder. Ortopediia Travmatologiia i Protezirovanie 8: 65-66
Hjortdal, O. 1975: Habitual dislocation of the temporomandibular joint. Den Norske Tannlaegeforenings Tidende 85(2): 68-72
Oğütcen, M. 1987: Habitual dislocation: a case report. Ankara Universitesi Dis Hekimligi Fakultesi Dergisi 14(2): 213-215
Tomaschewski, H.K. 1977: Habitual dorsal shoulder dislocation. Beitrage Zur Orthopadie und Traumatologie 24(2): 104-111
Jette, M. 1975: Habitual exercisers: a blood serum and personality profile. Journal of Sports Medicine 3(1): 12-17
Bracey, D.J.; Jeffreys, T.E. 1979: Habitual extensor tendon dislocation. Hand 11(3): 284-294
Chrousos, G.A.; Reingold, D.R.; Chu, F.C.; Cogan, D.G. 1985: Habitual head turning in spasmus nutans: an oculographic study. Journal of Pediatric Ophthalmology and Strabismus 22(3): 113-116
Walker, J.; Rang, M. 1992: Habitual hip dislocation in a child. Another cause of the snapping hip. Clinical Pediatrics 31(9): 562-563
Watson, P.; Hamilton, A.; Mollan, R. 1989: Habitual joint cracking and radiological damage. Bmj 299(6715): 1566
Simkin, P.A. 1990: Habitual knuckle cracking and hand function. Annals of the Rheumatic Diseases 49(11): 957
Zavaroni, I.; Angelo Bonati, P.; Luchetti, L.; Bonora, E.; Buonanno, G.; Bergonzani, M.; Pagliara, M.; Gnudi, L.; Butturini, L.; Passeri, M. 1989: Habitual leisure-time physical activity is associated with differences in various risk factors for coronary artery disease. Journal of Internal Medicine 226(6): 417-421
Dufek, M. 1975: Habitual luxation in tibiofibular joint. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 42(3): 234-236
Mongini, F.; Tempia-Valenta, G.; Conserva, E. 1989: Habitual mastication in dysfunction: a computer-based analysis. Journal of Prosthetic Dentistry 61(4): 484-494
Wedman, J.; Idema, N.K.; Feenstra, L. 1992: Habitual mouth breathing. Nederlands Tijdschrift Voor Geneeskunde 136(46): 2269-2271
Menke, W.; Schneider, T.; Schullien, P.; Michiels, I.; Müller, E.H. 1991: Habitual patella dislocation and Goldthwait's surgery. Aktuelle Traumatologie 21(6): 261-264
Huber, H.; Imhoff, A. 1988: Habitual peroneal tendon dislocation. Zeitschrift für Orthopadie und ihre Grenzgebiete 126(6): 609-612
Montoye, H.J.; Block, W.D.; Metzner, H.; Keller, J.B. 1977: Habitual physical activity and glucose tolerance. Males age 16-64 in a total community. Diabetes 26(3): 172-176
Menotti, A.; Monti, M. 1979: Habitual physical activity and responsibility at work as risk factors of fatal coronary heart disease. Giornale Italiano di Cardiologia 9(7): 668-673
Chantelau, E.; Wirth, R. 1992: Habitual physical activity in adult IDDM patients. a study with portable motion meters. Diabetes Care 15(11): 1727-1731
Saris, W.H. 1986: Habitual physical activity in children: methodology and findings in health and disease. Medicine and Science in Sports and Exercise 18(3): 253-263
Vanninen, E.; Uusitupa, M.; Siitonen, O.; Laitinen, J.; Länsimies, E. 1992: Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia 35(4): 340-346
Baranowski, A.; Malkowski, Z. 1977: Habitual posterior shoulder dislocation. Chirurgia Narzadow Ruchu i Ortopedia Polska 42(1): 55-58
Marcén, J.J.; Alejandre, M.C.; Grasa, B.; Ezquerra, J. 1992: Habitual presence of non-01 Vibrio cholerae in the aquatic environment. Enfermedades Infecciosas y Microbiologia Clinica 10(1): 62
Kovalkovits, I.; Ficzere, O. 1977: Habitual scapholunar dissociation. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 48(7): 428-430
Blaha, J. 1986: Habitual shoulder dislocation--its surgical treatment. Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 29(4-5): 387-405
Grio, R.; Marchino, G.L.; Zaccheo, F.; Mazza, O.; Cellura, A.; Giobbe, C.; Baccarini, G.; Malara, D. 1988: Habitual smoking during pregnancy. Minerva Ginecologica 40(3): 179-181
Wijma, K. 1991: Habitual somatizing (1). Non-traditional patient-physician relation in pychophysiologic disorders. Lakartidningen 88(7): 525; 527-528
Anonymous 1991: Habitual somatizing (2). Treatment is a contract between physician and patient. Lakartidningen 88(7): 528-529
Hofmeister, F.J. 1978: Habitual sponanteous abortion: what can be done for the patient?. Modern Medicine of Asia 14(2): 7
Piura, B.; Shoenfeld, Y. 1990: Habitual spontaneous abortions and the antiphospholipid autoantibody syndrome. Harefuah 118(3): 158-161
Nicodemo, P. 1991: Habitual technique of laparoscopic cholecystectomy. Annali Italiani di Chirurgia 62(4): 319-322
Griffin, P.P.; Wheelhouse, W.W.; Shiavi, R.; Bass, W. 1977: Habitual toe-walkers. a clinical and electromyographic gait analysis. Journal of Bone and Joint Surgery. American Volume 59(1): 97-101
Caselli, M.A.; Rzonca, E.C.; Lue, B.Y. 1988: Habitual toe-walking: evaluation and approach to treatment. Clinics in Podiatric Medicine and Surgery 5(3): 547-559
Rinsley, D.B. 1979: Habitual use?. Legal Aspects of Medical Practice 7(1): 28
Shepard, N.T.; Telian, S.A.; Smith-Wheelock, M. 1990: Habituation and balance retraining therapy. A retrospective review. Neurologic Clinics 8(2): 459-475
Jelínková, Z. 1977: Habituation and conditioning during 2nd sleep stage. Activitas Nervosa Superior 19(3): 211
Salzman, L.F.; Klein, R.H. 1978: Habituation and conditioning of electrodermal responses in high risk children. Schizophrenia Bulletin 4(2): 210-222
Reus, V.I.; Peeke, H.V.; Miner, C. 1985: Habituation and cortisol dysregulation in depression. Biological Psychiatry 20(9): 980-989
Golda, V.; Petr, R.; Pastrnák, A. 1976: Habituation and dishabituation in the picture of cortical visual evoked activity in human subjects. Activitas Nervosa Superior 18(1-2): 90-91
Talan, M.I.; Engel, B.T. 1988: Habituation and dishabituation to repeated mild cold exposures in C57BL/6J mice. Physiology and Behavior 44(6): 753-757
Barrett, R.H. 1975: Habituation and hypnosis. International Journal of Oral Myology 1(1): 1-3
Wolfman, C.; Da Cunha, C.; Jerusalinsky, D.; Levi de Stein, M.; Viola, H.; Izquierdo, I.; Medina, J.H. 1991: Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection. Brain Research 548(1-2): 74-80
Dokla, C.P.; Parker, S.C.; Thal, L.J. 1990: Habituation and retention of the head-shake response: lack of impairment by nucleus basalis magnocellularis lesions. Pharmacology Biochemistry and Behavior 35(1): 151-155
Rakitin, A.; Tomsic, D.; Maldonado, H. 1991: Habituation and sensitization to an electrical shock in the crab Chasmagnathus. Effect of background illumination. Physiology and Behavior 50(3): 477-487
Yehuda, S.; Chorover, S.L.; Carasso, R.L. 1979: Habituation and transfer during sleep in cats. International Journal of Neuroscience 9(4): 225-227
Wood, D.C. 1988: Habituation in Stentor: a response-dependent process. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 8(7): 2248-2253
Peachey, G. 1988: Habituation in orofacial myofunctional therapy. International Journal of Orofacial Myology: Official Publication of the International Association of Orofacial Myology 14(2): 3-5
Musiashchikova, S.S.; Siniaia, M.S. 1979: Habituation in the cortical division of the visceral analyzer. Neirofiziologiia 11(5): 412-418
Stoll, S.; Müller, W.E. 1991: Habituation in the open field and age-dependent object memory in female NMRi mice. Zeitschrift für Gerontologie 24(6): 300-301
Caekebeke, J.F.; Van Dijk, J.G.; Van Sweden, B. 1990: Habituation of K-complexes or event-related potentials during sleep. Electroencephalography and Clinical Neurophysiology. Supplement 41: 168-171
Lammers, W.J.; Badia, P. 1989: Habituation of P300 to target stimuli. Physiology and Behavior 45(3): 595-601
Farel, P.B.; Thompson, R.F. 1976: Habituation of a monosynaptic response in frog spinal cord: evidence for a presynaptic mechanism. Journal of Neurophysiology 39(4): 661-666
Bourbon, W.T.; Will, K.W.; Gary, H.E.; Papanicolaou, A.C. 1987: Habituation of auditory event-related potentials: a comparison of self-initiated and automated stimulus trains. Electroencephalography and Clinical Neurophysiology 66(2): 160-166
Kudriashova, I.V. 1987: Habituation of command neurons after administration of a vasopressin analog in the snail. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 37(4): 782-784
Kudryashova, I.V. 1988: Habituation of command neurons against the background of introducing an analogue of vasopressin in snails. Neuroscience and Behavioral Physiology 18(4): 280-281
Gapon, S.A.; Rosza, K.S. 1991: Habituation of completely isolated neurons of the edible snail to electrical stimulation. Neuroscience and Behavioral Physiology 21(3): 249-251
Verbaten, M.N.; Roelofs, J.W.; Sjouw, W.; Slangen, J.L. 1986: Habituation of early and late visual ERP components and the orienting reaction: the effect of stimulus information. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 3(4): 287-298
Krug, M.; Wagner, M.; Brödemann, R.; Matthies, H. 1989: Habituation of monosynaptic field potentials in the dentate gyrus of freely moving rats interferes with LTP. Brain Research 476(1): 163-166
Maltzman, I.; Weissbluth, S.; Wolff, C. 1978: Habituation of orienting reflexes in repeated GSR semantic conditioning sessions. Journal of Experimental Psychology. General 107(3): 309-333
Konarska, M.; Stewart, R.E.; McCarty, R. 1989: Habituation of sympathetic-adrenal medullary responses following exposure to chronic intermittent stress. Physiology and Behavior 45(2): 255-261
Geyer, M.A.; Tapson, G.S. 1988: Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1(2): 135-147
Leaton, R.N.; Jordan, W.P. 1978: Habituation of the EEG arousal response in rats: short- and long-term effects, frequency specificity, and wake--sleep transfer. Journal of Comparative and Physiological Psychology 92(5): 803-814
Miller, S.W.; Treft, R.L. 1979: Habituation of the acoustic startle response following lesion of the medial septal nucleus. Physiology and Behavior 23(4): 645-648
Fox, J.E. 1978: Habituation of the auditory startle reflex in decerebrate rats. Journal of Physiology 281: 34P-35P
Zbrozyna, A.W.; Krebbel, F. 1985: Habituation of the cold pressor response in normo- and hypertensive human subjects. European Journal of Applied Physiology and Occupational Physiology 54(2): 136-144
Stehouwer, D.J.; Campbell, B.A. 1978: Habituation of the forelimb-withdrawal response in neonatal rats. Journal of Experimental Psychology. Animal Behavior Processes 4(2): 104-119
Rees, C.T.; Spatz, H.C. 1989: Habituation of the landing response of Drosophila wild-type and mutants defective in olfactory learning. Journal of Neurogenetics 5(2): 105-118
Glanzman, D.L.; Schmidt, E.C. 1979: Habituation of the nictitating membrane reflex response in the intact frog. Physiology and Behavior 22(6): 1141-1148
Ferguson, I.T.; Lenman, J.A.; Johnston, B.B. 1978: Habituation of the orbicularis oculi reflex in dementia and dyskinetic states. Journal of Neurology Neurosurgery and Psychiatry 41(9): 824-828
Hulstijn, W. 1978: Habituation of the orienting response as a function of arousal induced by three different tasks. Biological Psychology 7(1-2): 109-124
McDonald, D.G.; Carpenter, F.A. 1975: Habituation of the orienting response in sleep. Psychophysiology 12(6): 618-623
Wester, K.; Sagvolden, T. 1979: Habituation of the orienting response: experimental evidence in favor of a "dual-process" theory. Behavioral and Neural Biology 26(4): 479-484
Fois, C.; Médioni, J.; Le Bourg, E. 1991: Habituation of the proboscis extension response as a function of age in Drosophila melanogaster. Gerontology 37(4): 187-192
Ross, R.J.; Ball, W.A.; Cohen, M.E.; Silver, S.M.; Morrison, A.R.; Dinges, D.F. 1989: Habituation of the startle reflex in posttraumatic stress disorder. Journal of Neuropsychiatry and Clinical Neurosciences 1(3): 305-307
May, M.L.; Hoy, R.R. 1991: Habituation of the ultrasound-induced acoustic startle response in flying crickets. Journal of Experimental Biology 159: 489-499
Condon, C.D.; Weinberger, N.M. 1991: Habituation produces frequency-specific plasticity of receptive fields in the auditory cortex. Behavioral Neuroscience 105(3): 416-430
Norris-Baker, C.; Scheidt, R.J. 1989: Habituation theory and environment-aging research: ennui to joie de vivre?. International Journal of Aging and Human Development 29(4): 241-257
Raja, N.; Goodson, M.; Chui, W.C.; Smith, D.G.; Rowbury, R.J. 1991: Habituation to acid in Escherichia coli: conditions for habituation and its effects on plasmid transfer. Journal of Applied Bacteriology 70(1): 59-65
Morris, N.; Jones, D.M. 1990: Habituation to irrelevant speech: effects on a visual short-term memory task. Perception and Psychophysics 47(3): 291-297
Milne, R.J.; Kay, N.E.; Irwin, R.J. 1991: Habituation to repeated painful and non-painful cutaneous stimuli: a quantitative psychophysical study. Experimental Brain Research 87(2): 438-444
Mangelsdorff, A.D.; Zuckerman, M. 1975: Habituation to scenes of violence. Psychophysiology 12(2): 124-129
Milne, R.J.; Gamble, G.D. 1989: Habituation to sham testing procedures modifies tail-flick latencies: effects on nociception rather than vasomotor tone. Pain 39(1): 103-107
Mertl, A.S. 1977: Habituation to territorial scent marks in the field by Lemur catta. Behavioral Biology 21(4): 500-507
Bokhov, B.B. 1975: Habituation to vestibular stimuli. Uspekhi Fiziologicheskikh Nauk 6(2): 3-29
Kaplan, P.S.; Werner, J.S. 1986: Habituation, response to novelty, and dishabituation in human infants: tests of a dual-process theory of visual attention. Journal of Experimental Child Psychology 42(2): 199-217
Miller, E.K.; Gochin, P.M.; Gross, C.G. 1991: Habituation-like decrease in the responses of neurons in inferior temporal cortex of the macaque. Visual Neuroscience 7(4): 357-362
Harris, E.W.; Lasher, S.S.; Steward, O. 1978: Habituation-like decrements in transmission along the normal and lesion-induced temporodentate pathways in the rat. Brain Research 151(3): 623-631
Usuki, S. 1988: Hachimijiogan and Tokishakuyakusan enhance deoxyribonucleic acid alpha-nucleotidyltransferase activity in relationship to DNA synthesis by ovarian follicles via a cyclic AMP system. American Journal of Chinese Medicine 16(1-2): 37-46
Usuki, S.; Usuki, Y. 1989: Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia. American Journal of Chinese Medicine 17(3-4): 225-241
Nottebaert, M.; Bertrand, P.; Amiri-Lamraski, M.H.; Delince, P. 1986: Hackethal's method of intramedullary nailing in compound cervico-diaphyseal fractures of the humerus in elderly patients. Acta Orthopaedica Belgica 52(6): 743-752
Taki, T.; Ogura, K.; Rokukawa, C.; Hara, T.; Kawakita, M.; Endo, T.; Kobata, A.; Handa, S. 1991: Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity. Cancer Research 51(6): 1701-1707
Derr, P.G. 1989: Hadamar, Hippocrates, and the future of medicine: reflections on euthanasia and the history of German medicine. Issues in Law and Medicine 4(4): 487-495
Williams, E.R.; Loh, S.Y.; McLafferty, F.W.; Cody, R.B. 1990: Hadamard transform measurement of tandem Fourier-transform mass spectra. Analytical Chemistry 62(7): 698-703
Penchas, S. 1987: Hadassah at 75. Israel Journal of Medical Sciences 23(3): 218-219
Budowle, B.; Waye, J.S.; Shutler, G.G.; Baechtel, F.S. 1990: Hae III--a suitable restriction endonuclease for restriction fragment length polymorphism analysis of biological evidence samples. Journal of Forensic Sciences 35(3): 530-536
Galutira, D.; Allderdice, P.W.; Davidson, W.S. 1991: HaeIIi RFLP for salivary proline-rich protein gene probe (pPRPII2.2RP). Nucleic Acids Research 19(23): 6667
Sone, N.; Fujiwara, Y. 1991: Haem O2 can replace haem a in the active site of cytochrome c oxidase from thermophilic bacterium PS3. Febs Letters 288(1-2): 154-158
Pierach, C.A. 1989: Haem and porphyria attacks. Lancet 2(8656): 213-214
Kordac, V.; Martásek, P. 1986: Haem arginate in acute hepatic porphyrias. British Medical Journal 293(6554): 1098
Mustajoki, P.; Tenhunen, R.; Tokola, O.; Gothoni, G. 1986: Haem arginate in the treatment of acute hepatic porphyrias. British Medical Journal 293(6546): 538-539
Tenhunen, R.; Tokola, O.; Lindén, I.B. 1987: Haem arginate: a new stable haem compound. Journal of Pharmacy and Pharmacology 39(10): 780-786
Padmanaban, G.; Venkateswar, V.; Rangarajan, P.N. 1989: Haem as a multifunctional regulator. Trends in Biochemical Sciences 14(12): 492-496
Kadir, F.H.; Moore, G.R. 1990: Haem binding to horse spleen ferritin. Febs Letters 276(1-2): 81-84
Goldberg, A.; Meredity, P.A.; Miller, S.; Moore, M.R.; Thompson, G.G. 1977: Haem biosynthesis and hepatic drug metabolism in lead poisoned rats. British Journal of Pharmacology 61(1): 134P-135P
Campbell, B.C.; Meredith, P.A.; Moore, M.R.; Brodie, M.J.; Thompson, G.G.; Goldberg, A. 1976: Haem biosynthesis and hydroxylation of phenazone during lead intoxication. Biochemical Society Transactions 4(6): 1088-1089
Rimington, C. 1989: Haem biosynthesis and porphyrias: 50 years in retrospect. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 27(8): 473-486
Brodie, M.J.; Moore, M.R.; Thompson, G.G.; Goldbrrg, A.; Holti, G. 1977: Haem biosynthesis in peripheral blood in erythropoietic protoporphyria. Clinical and Experimental Dermatology 2(4): 381-388
Campbell, B.C.; Rennie, N.; Thompson, G.G.; Moore, M.R.; Goldberg, A. 1978: Haem biosynthesis in rheumatoid disease. British Journal of Haematology 40(4): 563-569
Graham, A.M.; McColl, K.E.; Moore, M.R. 1989: Haem biosynthesis in the unconjugated hyperbilirubinaemias: observations in the Gunn rat model. Clinical Biochemistry 22(3): 177-179
Brown, S.B.; Docherty, J.C. 1978: Haem degradation in abnormal haemoglobins. Biochemical Journal 173(3): 985-987
King, R.F.; Brown, S.B. 1976: Haem degradation in dimethyl sulphoxide/water mixtures and pyridine/water mixtures. Biochemical Society Transactions 4(2): 299-301
Young, G.P.; Rose, I.S.; St John, D.J. 1989: Haem in the gut. I. Fate of haemoproteins and the absorption of haem. Journal of Gastroenterology and Hepatology 4(6): 537-545
Young, G.P.; St John, D.J.; Rose, I.S.; Blake, D. 1990: Haem in the gut. Part II. Faecal excretion of haem and haem-derived porphyrins and their detection. Journal of Gastroenterology and Hepatology 5(2): 194-203
Shedlofsky, S.I.; Sinclair, P.R.; Bonkovsky, H.L.; Healey, J.F.; Swim, A.T.; Robinson, J.M. 1987: Haem synthesis from exogenous 5-aminolaevulinate in cultured chick-embryo hepatocytes. Effects of inducers of cytochromes P-450. Biochemical Journal 248(1): 229-236
Konopka, L.; Hoffbrand, A.V. 1979: Haem synthesis in sideroblastic anaemia. British Journal of Haematology 42(1): 73-83
Haidas, S.; Zannos-Mariolea, L.; Matsaniotis, N. 1975: Red cell 2,3-diphosphoglycerate levels in children with hereditary haemolytic anaemias. British Journal of Haematology 31(4): 521-530
El Naggar, S.; Dreybrodt, W.; Schweitzer-Stenner, R. 1985: Haem-apoprotein interactions detected by resonance Raman scattering in Mb- and Hb-derivates lacking the saltbridge His146 beta-Asp94 beta. European Biophysics Journal: Ebj 12(1): 43-49
Dover, S.B.; Graham, A.; Fitzsimons, E.; Moore, M.R.; McColl, K.E. 1991: Haem-arginate plus tin-protoporphyrin for acute hepatic porphyria. Lancet 338(8761): 263
Ketterer, B.; Srai, K.S.; Christodoulides, L. 1976: Haem-binding proteins of the rat liver cytosol. Biochimica et Biophysica Acta 428(3): 683-689
Geerlof, A.; Dokter, P.; van Wielink, J.E.; Duine, J.A. 1989: Haem-containing protein complexes of Acinetobacter calcoaceticus as secondary electron acceptors for quinoprotein glucose dehydrogenase. Antonie van Leeuwenhoek 56(1): 81-84
Ignarro, L.J. 1992: Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochemical Society Transactions 20(2): 465-469
Ignarro, L.J. 1990: Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacology and Toxicology 67(1): 1-7
Schneider-May, U.; Struck, H. 1977: Haemaccel as a model substance for the diaplacentar passage in the rabbit. Die Medizinische Welt 28(8): 384-385
Lyon, M.; Mayne, P. 1991: Haemaccel--good product, poor packaging. Anaesthesia and Intensive Care 19(2): 301-302
Semjén, G.; Magyar, T. 1991: Haemagglutinating and adhesive activity of Bordetella bronchiseptica treated with sub-minimal inhibitory concentrations of gentamicin. Acta Veterinaria Hungarica 39(3-4): 121-126
Srinivasappa, J.; Garg, S.K. 1976: Haemagglutinating property of buffalo-pox virus. Indian Journal of Experimental Biology 14(4): 493-494
Ramachandran, V.G.; Varghese, A. 1988: Haemagglutination and electron microscopy of enterotoxigenic and nontoxigenic Escherichia coli. Indian Journal of Medical Research 88: 7-12
Baldassarri, L.; Pantosti, A.; Caprioli, A.; Mastrantonio, P.; Donelli, G. 1989: Haemagglutination and surface structures in strains of Clostridium spiroforme. Fems Microbiology Letters 51(1): 1-4
Bistoni, F.; Marconi, P.; Tissi, L.; Bastianini, L.; Pitzurra, M. 1978: Haemagglutination antibody titre levels which give certain protection against tetanus toxin. Bollettino Dell'istituto Sieroterapico Milanese 57(5): 590-595
Marwah, G.S.; Arora, S.; Prabhakar, H. 1989: Haemagglutination antibody titres and immunoglobulin levels in cases of Plasmodium infection. Indian Journal of Medical Research 89: 326-329
Hopkins, R.; Watt, A.D.; Ross, S. 1978: Haemagglutination assay for HBsAg -- a new approach to reagent preparation. Journal of Immunological Methods 20: 35-41
Bingham, R.W.; Madge, M.H.; Tyrrell, D.A. 1975: Haemagglutination by avian infectious bronchitis virus-a coronavirus. Journal of General Virology 28(3): 381-390
Vel, W.A.; Namavar, F.; Marian, A.; Verweij-van Vught, J.J.; Pubben, A.N.; MacLaren, D.M. 1986: Haemagglutination by the Bacteroides fragilis group. Journal of Medical Microbiology 21(2): 105-107
Olaleye, O.D.; Omilabu, S.A.; Baba, S.S.; Fagbami, A.H. 1990: Haemagglutination-inhibiting (HI) antibodies against strains of influenza a virus in horse and pig sera in Nigeria. Journal of Hygiene Epidemiology Microbiology and Immunology 34(4): 365-370
Strízová, V.; Hrusková, J.; Syrücek, L.; Brücková, M.; Berkovicová, V. 1979: Haemagglutination-inhibiting and neutralizing antibodies to type 3 and 5 rhinoviruses in human sera and nasal washings. Journal of Hygiene Epidemiology Microbiology and Immunology 23(3): 348-352
Olaleye, D.O.; Baba, S.S.; Omilabu, S.A.; Fagbami, A.H. 1991: Haemagglutination-inhibiting antibodies against influenza a and B in human sera collected from five ecological zones in Nigeria. Journal of Hygiene Epidemiology Microbiology and Immunology 35(4): 395-406
Sekeyová, M.; Gresíková, M.; Hrúzik, J.; Lukacovicová, Z. 1976: Haemagglutination-inhibition antibodies against some arboviruses in the sera of Vietnamese citizens. Casopis Lekaru Ceskych 115(46): 1432-1434
Okuno, Y.; Yamanishi, K.; Takahashi, Y.; Tanishita, O.; Nagai, T.; Dantas, J.R.; Okamoto, Y.; Tadano, M.; Takahashi, M. 1986: Haemagglutination-inhibition test for haemorrhagic fever with renal syndrome using virus antigen prepared from infected tissue culture fluid. Journal of General Virology 67: 149-156
Turner, G.C.; Green, H.T.; Blundell, V.D. 1978: E-Antigen: a link between immune response and infectivity in hepatitis B?. Journal of Hygiene 81(3): 405-414
Ghendon, Y.; Markushin, S.; Heider, H.; Melnikov, S.; Lotte, V. 1986: Haemagglutinin of influenza A virus is a target for the antiviral effect of Norakin. Journal of General Virology 67: 1115-1122
Gerlier, D.; Garnier, F.; Forquet, F. 1988: Haemagglutinin of measles virus: purification and storage with preservation of biological and immunological properties. Journal of General Virology 69: 2061-2069
Garten, W.; Kuroda, K.; Schuy, W.; Naruse, H.; Scholtissek, C.; Klenk, H.D. 1985: Haemagglutinin transport mutants. Vaccine 3(3 Suppl): 227-229
Saxena, V.K.; Yadava, J.N. 1985: Haemagglutinins and enterotoxins in Escherichia coli strains from human urinary tract infections. Indian Journal of Medical Research 81: 35-40
Tavendale, A.; Old, D.C. 1985: Haemagglutinins and adhesion of Escherichia coli to HEp2 epithelial cells. Journal of Medical Microbiology 20(3): 345-353
Joss, A.W.; Evans, J.; Veitch, D.T.; Arthur, E.; Steel, C.M. 1976: Haemagglutinins produced in vitro by human lymphoblastoid cells. Journal of Immunogenetics 3(5): 323-328
Van Acker, P.; Derom, F.; De Gendt, G.; Berzsenyi, G. 1975: Haemagnioma of the liver in newborn infant. Acta Chirurgica Belgica 74(5): 545-550
Moss, C.; Robson, B.J. 1988: Haemangiectatic hypotrophy associated with Perthe's disease. Clinical and Experimental Dermatology 13(4): 237-239
Biswas, S.K.; Sen, S.; Pal, N.C.; Sengupta, K.P. 1975: Haemangio-endothelioma of the liver in an infant with cardiac failure. Journal of the Indian Medical Association 65(7): 207-209